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use of plant genetic resources. In this respect the balance between the need to keep access to 
genetic resources unfettered so that anyone can use them and the need to allow innovators to 
claim certain property rights over their creations as a means of encouraging and rewarding 
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to germplasm accessed from the public domain before a grant of intellectual property rights 
can be sought”.  The article examines the practices of centres of the Consultative Group on 
International Agricultural Research (CGIAR) and seeks to help the reader work through and 
evaluate a range of different options for how rules regarding derivatives might be handled in 
the future. In addition, this publication brings together a number of key related documents: 
the agreements between the CGIAR centres and the Food and Agriculture Organization of 
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This publication brings together under one 
roof, a number of documents pertaining to the 
interface between plant genetic resources that 
are in the public domain, and intellectual prop-
erty rights regimes. The relationship between 
the two is a dynamic one, characterized by 
some degree of tension and even controversy. 
It has been this way for many years.
Society’s interests certainly lie in encourag-
ing innovation with and use of plant genetic 
resources. The trick lies in balancing the need 
to keep access to genetic resources unfettered 
so that anyone can use them with the need to 
allow innovators to claim certain property 
rights over their creations as a means of en-
couraging and rewarding such work. Centres 
of the Consultative Group on International 
Agricultural Research (CGIAR) hold vast col-
lections of plant genetic resources ‘in trust’ for 
the international community. Under agree-
ments with the Food and Agriculture Organi-
zation of the United Nations (FAO), samples 
are distributed under the terms of a Material 
Transfer Agreement (MTA) that enjoins re-
cipients from claiming intellectual property 
rights over the material received. However, 
technologies for manipulating and employing 
genetic resources have been developing rap-
idly. The question of how much or how little 
must be done to germplasm accessed from the 
public domain before intellectual property 
rights can be granted is ultimately a question 
about how to balance interests. At the same 
time it is also technically a complex matter. 
The centrepiece of this publication is an 
article that focuses on this question – the 
question of derivatives – that was published 
in the Journal of World Intellectual Property. We 
are grateful to the publishers of this journal 
for granting permission for us to use the text 
in its entirety in this publication. The article 
examines the practices of centres of the 
CGIAR, and seeks to help the reader work 
through and evaluate a range of different 
options for how rules regarding derivatives 
might be handled in the future. In addition 
to the article, this publication brings together 
a number of key related documents: the FAO-
CGIAR agreements placing plant germplasm 
held by the centres under the auspices of the 
FAO; the joint statements issued by FAO and 
the CGIAR concerning these agreements; the 
two MTAs that the CGIAR Centres have used 
in recent years; and the relevant sections of 
the International Treaty on Plant Genetic 
Resources for Food and Agriculture, which 
will provide the legal context and framework 
for future rule systems dealing with the in-
terface between germplasm included within 
the Treaty’s Multilateral System (including 
that held by the CGIAR centres) and intel-
lectual property rights regimes.
While this publication is aimed primarily 
at those interested in the management of the 
CGIAR-held collections, we are aware that the 
issues discussed herein are of critical impor-
tance to the implementation of the Interna-
tional Treaty, particularly at this moment when 
the Treaty’s Governing Body is preparing to 
negotiate the terms of their standard Material 
Transfer Agreement. Inevitably, any institution 
or body that seeks to accommodate both pub-
lic (or multilateral) and private systems of 
ownership of plant genetic resources must set 
the borders and defi ne the relationships be-
tween the two in ways that are clear enough 
so that those accessing germplasm can be 
certain of what is allowed and what is not 
while using the resource in research and breed-
ing. Such defi nitions must also be clear enough 
to facilitate enforcement of the rules. 
With this publication, those interested and 
involved in ongoing discussions of this topic 
will fi nd a convenient resource that draws 
together both critical analyses and basic 
background documents. The aim of this pub-
lication is not to provide defi nitive answers, 
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Introduction
How much, or in what ways, must one culti-
var or crop breeding line vary from another in 
order to be considered different and distinct? 
Conversely, under which conditions might 
one be so similar—even if not exactly the 
same—as to be judged essentially as being the 
same as the other? Such questions are not just 
for philosophers. In a world in which owner-
ship and control of crop varieties can defi ne 
the limits of the availability of germplasm for 
use in breeding programmes, as well as the 
potential for profi ts for commercial varieties, 
the question of derivatives becomes critical to 
the agricultural community in general and to 
plant breeders, legal experts and policy-mak-
ers in particular.
The “question” of derivatives has no single 
answer. This is probably as it should be, for 
the question arises in different circumstances 
and it is quite possible that a defi nition ap-
propriate for intellectual property right (IPR) 
laws concerning new varieties would not be 
ideal for describing how much needs to be 
done to “public” germplasm before a claim 
can be made for a new  invention.
This article takes as its point of departure 
the management of plant genetic resources 
that are publicly available today from the 
Centres supported by the Consultative Group 
on International Agricultural Research 
(CGIAR) under Agreements with the Food 
and Agriculture Organization of the United 
Nations (FAO). These Agreements [see 
 Annexe 1, now in their tenth year, are ex-
pected to be of limited future duration, for 
the International Treaty on Plant Genetic 
Resources for Food and Agriculture [see 
 Annexe 2 for selected parts of the Treaty] 
provides the legal framework now that it has 
entered into force.1 In the meantime, a con-
sideration of the current FAO-CGIAR Agree-
ments is warranted because they still 
constitute the framework within which thou-
sands of materials are distributed annually; 
they provide a useful structure within which 
to consider the question of derivatives, not 
from the vantage point of an IPR regime, but 
from the perspective of the distribution and 
use of “public materials” and the attendant 
concerns of maintaining availability for use; 
and they are part of the history associated 
with the new Treaty—how countries have 
related to them says something about their 
intentions and about how certain provisions 
in the Treaty should be understood. A more 
detailed look at the question of derivatives, 
primarily placed within the context of the 
FAO-CGIAR Agreements, is thus of continu-
ing interest and value.
The question of derivatives in the context 
of the Agreements, or of the Treaty, is one that 
ultimately comes to focus on how to promote 
and encourage research and the use of plant 
genetic resources for food and agriculture 
that are publicly held. Many believe that IPR 
systems provide useful incentives in this re-
gard. On the other hand, if genetic materials 
become “locked up”, research and use might 
be inhibited. How then, can public institu-
tions distribute germplasm, encourage its use 
and ensure that those same resources remain 
available for access and use by the next per-
son? This is the question ultimately addressed 
in this article. The discussion of the FAO-
CGIAR Agreements is useful in its own right 
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but also serves as a surrogate for considering 
the complexities that the public sector faces 
in the management of plant genetic resourc-
es for food and agriculture.
The article does not address what may be 
a different set of concerns and goals associ-
ated with the question of derivatives in the 
context of IPR law, in particular those related 
to the Union for the Protection of New Variet-
ies of Plants (UPOV). It is not intended as a 
comment upon or critique of how such mat-
ters are dealt with under this or other IPR 
legal regimes.
In 1994, the Centres of the CGIAR placed 
collections of plant genetic resources “in 
trust” under the auspices of the FAO. In 
identical written Agreements [Annexe 
1] signed separately with the FAO, the Cen-
tres pledged to manage and administer the 
“accessions”2 in accordance with internation-
ally accepted standards (including long-term 
storage), not to claim ownership or IPRs over 
the materials and to make the materials 
freely available to other users, provided that 
those recipients agreed to certain terms (i.e. 
not to claim ownership or seek IPRs).
In discharging their responsibilities under 
the FAO Agreement, the CGIAR Centres dis-
tribute covered materials under the terms of 
a Material Transfer Agreement (MTA) [Annexe 
3], the wording of which they developed in 
conjunction with the FAO and the FAO Com-
mission on Genetic Resources for Food and 
Agriculture. Through the original version of 
the MTA, a recipient “agree[d] not to claim 
ownership over the germplasm to be received, 
nor to seek IPRs over that germplasm or re-
lated information.” The language of the MTA 
has recently been changed  [Annexe 4]at the 
request of the FAO Commission on Genetic 
Resources for Food and Agriculture. The new 
language enjoins recipients from seeking IPRs 
“over that material, or its genetic parts or 
components, in the form received”. The re-
cipient is also not allowed “to seek IPRs over 
related information received”.
The language in both versions, original 
and current, gives rise to questions about the 
meaning of “germplasm” and about what 
recipients can and cannot do with the materi-
als they receive vis-à-vis their incorporation 
into varieties for which IPRs might be sought. 
The issues and concerns raised in this article 
are not specifi c to either version of the MTA 
used by Centres of the CGIAR. Indeed, the 
Governing Body of the new Treaty, when it 
meets to negotiate and agree upon the word-
ing of the standard MTA to be used by the 
Treaty’s Contracting Parties (countries) as 
well as by CGIAR Centres, will almost in-
evitably face the issue of how to deal with 
derivatives. It is also quite possible that the 
Governing Body will choose to make use of 
the CGIAR’s MTA as a starting point—a ne-
gotiating draft—for the formulation of the 
Treaty’s standard MTA. Nevertheless, so as 
not to pre-judge the actions of the Treaty’s 
Governing Body, this article, in most in-
stances, refers to the MTA used by the CGIAR 
(the current as well as the previous version) 
and to the Agreements between the FAO and 
the CGIAR Centres that the MTA is meant to 
help implement. Despite certain changes in 
terminology and formulation, there is no 
reason to believe that the Treaty will represent 
a radical break with the past—with the FAO-
CGIAR Agreements—in terms of what or 
how much must be done to received germ-
plasm before a valid claim of ownership of a 
new product can be asserted consistent with 
the terms of the MTA. Thus, a discussion of 
one should be relevant to the other.
2  According to Elsevier’s Dictionary of Plant Genetic Resources, an accession is: “An entry in a genebank. 
A sample, cultivated variety, strain, or bulk population maintained at a genetic resources centre or in 
a plant breeding programme, for conservation or use, e.g. a sample of seeds representing a cultivar, 
breeding line, or a collected fi led sample, which is held in storage.” See International Board for Plant 
Genetic Resources, Elsevier’s Dictionary of Plant Genetic Resources, Elsevier, Amsterdam, 1991.
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Should we interpret “germplasm” to 
mean every allele in every sample that falls 
under the FAO-CGIAR Agreements? Or does 
the term “designated germplasm” refer to an 
accession, which is the actual unit of designa-
tion with the FAO? What recipients can and 
cannot do with the “designated germplasm” 
depends in part on how the term is defi ned. 
Is it the accession itself? If so, a recipient could 
not take out IPRs on that material “as re-
ceived”. Is it every gene and allele in the ac-
cession? In this case, it could be argued that 
the material could not be used in any way in 
any breeding programme resulting in an IPR-
protected cultivar. In other words, none of 
the genes or alleles found in the CGIAR col-
lections held under the FAO could end up in 
a protected cultivar or any construction cov-
ered by IPRs.
What recipients can do with the germ-
plasm is directly determined by the wording 
of the MTA, the instrument used to enforce 
the FAO-CGIAR Agreements. At present, the 
standard MTA used system-wide in the 
CGIAR is vague and subject to confl icting 
interpretations. It is clear that the MTA pro-
hibits intellectual property protection for the 
accession itself, but such protection would 
not properly be granted under any existing 
IPR legislation. The MTA, however, does not 
explicitly deal with the question of deriva-
tives. In the new MTA, the question of what 
rights might be sought in connection with 
components of designated accessions is more 
directly addressed than in the previous ver-
sion but is still left somewhat ambiguous by 
a formulation which prohibits IPRs on parts 
and components “in the form received”.
The FAO-CGIAR Agreements aim to en-
courage use of the material. This aim is ad-
vanced by promoting research on the 
materials but hampered if this research on 
components leads to IPR protection that 
would restrict the further use of the accession, 
including the deployment of genes contained 
within it. The challenge is in defi ning more 
precisely what can be done by recipients in a 
way that will encourage research and yet not 
hamper further access to and use of the mate-
rial. In this “age of biotechnology”, few ques-
tions will be as important in determining the 
future status and usefulness of this invaluable 
resource.
Section I of this article examines the lan-
guage in the original FAO-CGIAR Agree-
ments, in the associated MTA and in “Joint 
Statements” issued by the FAO and the 
CGIAR [Annexes 5 and 6], in an effort to 
understand legally what the term “germ-
plasm and related information” means as 
employed by the FAO and the CGIAR Centres 
as well as to gain insight into the intentions 
of the Parties to the Agreement. It also looks 
at various alternative interpretations of the 
word “germplasm” and of the implications 
of using these different alternatives.
Section II looks at a related subject: what 
does it really mean to say that a recipient of 
germplasm cannot take out IPRs on certain 
material? What would the recipient have to 
do to the material—how large would the 
changes have to be—before the recipient 
could properly claim IPRs? This Section iden-
tifi es and, as part of an intellectual exercise, 
systematically works through a rather large 
number of possible approaches and their 
implications and concludes by describing one 
or two promising alternatives for dealing 
with the problem of derivation in the context 
of a “facilitated access” regime such as those 
of both the current FAO-CGIAR Agreements 
and the International Treaty on Plant Ge-
netic Resources for Food and Agriculture.
I. Searching for defi nitions and intent
A. The problem of defi nition
The text of the FAO-CGIAR Agreements 
contains no section on defi nitions of terms. It 
does, of course, address the question of what 
is covered under the Agreements.
The Preamble to the Agreements observes 
that:
“… the germplasm accessions have 
been donated or collected on the 
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understanding that these accessions 
will remain freely available and that 
they will be conserved and used in 
research on behalf of the international 
community, in particular developing 
countries.”
This statement seems to reveal an assump-
tion that it is the accessions that are desig-
nated, because it was the accessions that were 
donated with the understanding that “these 
accessions will remain freely available …” 
(emphasis added).
Article 2 states that the Centres place un-
der the auspices of the FAO:
“… the collections of plant genetic re-
sources listed in the Appendix hereto 
(hereinafter referred to as the ‘desig-
nated germplasm’), as catalogued and 
published by the Centre in print or 
machine-readable form … The list of 
designated germplasm will be updated 
every two years as new accessions are 
added to the collection.”
This is as clear a defi nition of “germ-
plasm” as one will fi nd in the Agreements. 
In this Article, “designated germplasm” 
means the “collections” being placed under 
FAO auspices. Moreover, the list of desig-
nated germplasm—that is, the list of what 
is comprised by the collection—will be up-
dated as “accessions” are added to the col-
lection. The “designated germplasm” is, 
therefore, a collection of accessions that have 
been included in the list by the individual 
Centres and sent to the FAO as part of the 
Agreements. Designated accessions thus 
constitute the collection placed under the 
FAO. This interpretation is consistent with 
the “list” originally provided to and ac-
cepted by the FAO—a list of “accessions”. 
The Article specifi es that it is the collections 
(which it is calling “designated germplasm”) 
“as catalogued and published by the Centre” 
that are the subject of treatment under the 
Agreements. As Centres keep catalogues of 
accessions, but not of individual genes or 
alleles, it would appear clear that the Parties 
intended “designated germplasm”, in prac-
tice, to mean designated “accessions” and 
not designated “alleles”.
The foregoing interpretation is buttressed 
by wording contained in statements issued 
jointly by the FAO and the CGIAR, as well as 
by existing practice. In the fi rst Joint State-
ment,3 [Annexe 5] the FAO and the CGIAR 
addressed the question of what was meant 
by “related information” in the term “germ-
plasm and related information” found in 
Article 3 of the Agreements and in the origi-
nal MTA used by the CGIAR Centres. The 
Statement says that this is “information 
which has been compiled with respect to 
individual accessions …” (emphasis added). 
Were “germplasm” in the phrase “germplasm 
and related information” to refer to genes, 
presumably “related information” would 
refer not to accession-level information but 
to sub-accession level information, such as 
genomic and molecular information.
In the second Joint Statement,4  [Annexe 6] 
the FAO and the CGIAR address a number 
of subjects including the management of 
designated germplasm. Mention is made of 
factors that might constrain Centres in sup-
plying designated germplasm—factors such 
as “seed viability”. The Statement acknowl-
edges that Centres must use “some discretion 
in determining the size and number of sam-
ples to be provided at any given time to a 
particular recipient” and notes that:
“Centres are not obligated to distribute 
seed or other designated materials 
when such distributions would re-
duce stocks below accepted levels for 
conservation purposes or when the 
request is for such a number of samples 
3  Issued at the time of the signing of the Agreements in 1994; available at: ‹www.singer.cgiar.org/
booklet.pdf›.
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or quantity of a particular accession 
as to pose an undue burden on the 
fi nancial or technical resources of the 
centre or on its ability to meet requests 
from others.”
In each of the Joint Statements, a strong 
argument can be made that “designated 
germplasm” was assumed to equal desig-
nated accessions.
Were the text of the FAO-CGIAR Agree-
ments clear and unambiguous, the question 
of alternative interpretations of the word 
“germplasm” would be of little note. The fact 
is that “germplasm” in common scientifi c 
usage means something different—something 
more—than the term “accession” covers.
Article 1 of the FAO-CGIAR Agreements 
asserts that the Agreement “shall be construed 
and applied in a manner consistent with the 
provisions of the Convention on Biological 
Diversity and the International Undertaking 
on Plant Genetic Resources.” Unfortunately, 
neither of these defi ne “germplasm”. The U.S. 
National Academy of Sciences, however, has 
defi ned “germplasm” as:
“… seeds, plants, or plant parts that 
are useful in crop breeding, research, or 
conservation because of their genetic 
attributes. Plants, seed, or cultures 
that are maintained for the purposes 
of studying, managing, or using the 
genetic information they possess.”5
The Academy defi nes “genetic resources” 
as being synonymous with “germplasm”. The 
Convention on Biological Diversity does not 
defi ne “germplasm”, but it does defi ne “ge-
netic resources” as “genetic material of ac-
tual or potential value”. It defines also 
“genetic material” as “any material of plant, 
animal, microbial or other origin containing 
functional units of heredity”.
The above defi nitions from the Conven-
tion on Biological Diversity and the U.S. 
National Academy of Sciences cannot close 
the door on the debate.6 They seem to point 
to an interpretation of “germplasm” which 
would focus at the accession level. However, 
they would also allow for a broader interpre-
tation—one that might begin with the acces-
sion and proceed to include all of the 
functional units of heredity found within the 
accession.
B. Assessing the use and impact of 
different defi nitions
CGIAR Centres holding collections under the 
auspices of the FAO manage those collections 
as a collection of accessions, not, in practical 
terms, as a collection of genes and alleles 
physically separate from accessions. Acces-
sions, not genes and alleles, are distributed, 
recorded and tracked.7
Were “germplasm” in the FAO-CGIAR 
Agreements to refer to accessions, then the 
Agreements would be understood as pro-
hibiting claims of ownership or the applying 
for IPRs on the “accessions, as received”. 
Enforcement of the FAO-CGIAR Agree-
ments, while not simple, would be rela-
tively straightforward: recipients would be 
prohibited from taking out IPRs on the ac-
cessions. Controversies might be resolved 
by comparing the material for which protec-
tion is sought to the accessions still held in 
the Centre genebank. Given the limited 
number of patent and plant breeder rights 
certifi cates sought annually, the job of ensur-
ing that “designated germplasm” remains 
4  Issued in 1998; available at: ‹www.singer.cgiar.org/booklet.pdf›.
5  National Research Council, Managing Global Genetic Resources: Agricultural Crop Issues and Policies, 
National Academy Press, Washington, D.C., 1993.
6  The question of extracted DNA, for example, remains unresolved, but will have to be addressed 
in some way in negotiations for a standard MTA for use in association with the Treaty. Specifi c 
treatment of this issue is beyond the scope of this article.
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free of IPRs and in the public domain would 
be manageable, even if an accession or two 
periodically “slipped through the cracks”. 
Of approximately 500,000 accessions “des-
ignated” by the CGIAR, fewer than 200 
cases of improper IPR applications/protec-
tion have been alleged. All but a handful of 
these allegations have proven baseless. Al-
legations associated with fewer than one-
thousandth of  one percent  of  total 
distributions have been substantive enough 
to provoke action, and in all relevant cases 
the result was the withdrawal of the applica-
tion or of the grant of protection. The low 
rate of “abuse” does not, of course, excuse 
those situations in which it has taken place 
but it does add context and perspective to 
the magnitude of the “problem”.
As shown in Table 1, the CGIAR collec-
tions are comprised, apparently more than 
most government or private collections, of 
landraces/farmers’ varieties. One would not 
expect to see tremendous interest in access-
ing such materials for the purpose of acquir-
ing IPRs on them without alteration or 
improvement.
While the evidence suggests that few have 
a strong interest in seeking IPRs on desig-
nated germplasm, as received, many public- 
and private-sector institutions are very 
interested in having access to these materials 
for research and incorporation into their 
breeding programmes.
Between 1992 and 1994 (the period for 
which the most comprehensive data is avail-
able), genebanks of the eleven Centres hold-
ing designated germplasm distributed 
406,211 individual samples.8 Nearly one-third 
of this material (130,508 samples) was distrib-
uted to National Agricultural Research Sys-
tems (NARS) in developing countries, while 
54 percent went to CGIAR Centres them-
selves for their own breeding programmes. 
While distribution varies by Centre and crop, 
“most centres distribute at least 10% of their 
total accessions annually—a rate that is 
higher than that for most national gene-
banks”, according to the FAO.9
Virtually all “improved” material distrib-
uted by CGIAR Centres contains alleles found 
within the designated accessions. Likewise, 
virtually every accession held in a national 
7  However, with the fast evolving technologies in the area of molecular genetics and the impact this 
has on the way germplasm is being managed and distributed, it will be important to re-visit the 
defi nitions of germplasm collection and accession. The following hierarchical sequence of terms 
should be kept in mind when doing so:
 Collection = set of accessions
 Accession = set of one or more genotypes, treated as a unit within a collection
 Genotype = the particular combination of genes of an individual plant
 Haplotype = the symbolic representation of a specifi c combination of linked alleles of related genes
 Gene = one or more alleles at the same locus of a chromosome.
Table 1: Summary comparison of the composition of cgiar, government and private 
collections of plant genetic resources (percentages of total collection content)
Type of material CGIAR Governmental Private
Landraces and old cultivars 59 12 9
Wild species and weedy relatives 14 4 6
Advanced cultivars and breeders’ lines 27 18 47
Other/mixed material – 66 38
Source: FAO, The State of the World’s Plant Genetic Resources for Food and Agriculture, FAO, Rome, 1998.
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genebank would contain genetic material 
found within the collections of designated 
accessions held by CGIAR Centres.10 Use of 
this “designated germplasm” (broadly de-
fi ned) is pervasive in agricultural systems 
throughout the world. For example:
“More than 80% of the wheat and 
maize varieties being released by na-
tional agricultural partners are based 
on CIMMYT’s germplasm research. 
Over 75% of the developing world’s 
total wheat area and about a third of its 
maize area are now devoted to grow-
ing CIMMYT-related varieties.”11
Any changes made or restrictions im-
posed on the use of CGIAR-held materials 
could have tremendous ripple effects through-
out world agriculture.
In practice, both the CGIAR Centres and 
the FAO have assumed that the MTA’s prohi-
bition against a recipient claiming ownership 
or applying for IPRs over the designated 
germplasm refers to the accession, as received, 
not to every component of it when incorpo-
rated into a new cultivar. This approach al-
lows for recipients, in conformity with the 
MTA,12 to use the material in breeding pro-
grammes and produce a new cultivar that is 
legitimately eligible for protection under plant 
breeder’s rights laws.13 While standards and 
criteria for protection under UPOV-style cul-
tivar protection schemes are relatively 
straightforward, it must be acknowledged 
that the MTA used by the CGIAR Centres and 
approved by the FAO is less so. Signifi cantly, 
it does not specify how much or how little 
must be done with the material received be-
fore the recipient can apply for IPR protection 
and still be in compliance with the MTA (see 
Section II of this article).
One could make a radically different in-
terpretation of the FAO-CGIAR Agreements 
and the related MTAs than that offered above. 
One could assume that each allele in each 
accession designated under the Agreements 
with the FAO is covered by those Agree-
ments. This would force an alternative inter-
pretation of the MTA’s prohibition against 
applying for IPRs over the designated germ-
plasm. This approach is fatally fl awed, as the 
new Treaty on Plant Genetic Resources itself 
demonstrates. Countries would not have 
based their benefi t-sharing mechanism under 
the Treaty on royalties coming from the use 
of multilateral-system material in IPR-pro-
tected cultivars had they wished to prohibit 
each and every gene from this material from 
appearing in a protected cultivar. Neverthe-
8  System-wide Programme on Genetic Resources (SGRP), Report of the Internally Commissioned 
External Review of CGIAR Genebank Operations, IPGRI, Rome, 1996.
9  FAO, The State of the World’s Plant Genetic Resources for Food and Agriculture, FAO, Rome, 1998. For a 
more recent and more detailed analysis of transfers of germplasm to and from Centres of the CGIAR, 
see C. Fowler, M. Smale and S. Gaiji, Unequal Exchange? Recent Transfers of Agricultural Resources and 
their Implications for Developing Countries, Development Policy Review, Vol. 19, No. 2, 2001.
10  In fact, all humans also contain genes and alleles found within the designated accessions.
11  CGIAR, Recent Accomplishments of the CGIAR International Agricultural Research Centers, CGIAR, 
Washington, D.C., 1998.
12  Unless otherwise specifi ed, references to the MTA refer equally to the MTA employed by the CGIAR 
in 2004 and to the previous MTA used by the Centres. As noted, these MTAs are similar and both 
were developed in consultation with and with the approval of the FAO and the FAO Commission.
13  The innovation here is the result of gene “reassortment” after meiosis, as a result of human effort. 
Even though all the genes may have been in the genepool previously, the distinct genotype was 
not previously available.
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less, some individuals have argued that re-
cipients should be prevented from applying 
for IPRs on any cultivar that contains as much 
as a single allele found in designated mate-
rial acquired under the terms of the MTA.
Such an interpretation would give rise to 
massive enforcement problems which neither 
the CGIAR nor the FAO have the capacity to 
address at present. No inventory exists of the 
alleles in CGIAR-designated germplasm col-
lections. Moreover, the majority of alleles are 
widespread geographically within species 
and many are common among species as 
well. They are to be widely found in many 
breeding institutions. It would be diffi cult, if 
not impossible, in many cases to prove that 
the source of the gene or allele was the acces-
sion provided by the CGIAR Centre under 
the terms of the MTA. Furthermore, no 
mechanism exists today for routine monitor-
ing of the use or presence of alleles in new 
cultivars. While this might be possible techni-
cally, the costs of checking each new applica-
tion for breeder’s rights against all alleles 
received by the applicant from the CGIAR 
would be prohibitive. Needless to say, had 
the FAO and the CGIAR chosen to move to-
wards such a defi nition, legal expenses would 
have dramatically increased.
Despite the overwhelming problems in-
volved in enforcing such an interpretation, 
assertion of this position would likely result 
in a precipitous decline in requests for mate-
rial, thus mitigating enforcement diffi culties. 
For legal and political reasons, many crop 
breeding organizations would not be inter-
ested in gaining access to material that could 
not be used to produce a protectable culti-
var.14 This certainly applies to the private 
sector, but more and more we fi nd that pub-
lic-sector institutions are protecting the prod-
ucts of their research programmes. Thus, one 
would have to weigh the costs in terms of 
reduced access and reduced use of the mate-
rials. The “benefi t” would be that none of the 
material would end up in a protected cultivar. 
The purpose of this strategy is unclear, how-
ever, when one considers that under UPOV-
style breeder ’s rights, protection of the 
cultivar does not prevent future use of the 
material by others—even for the purpose of 
producing another protected cultivar. In 
other words, under the UPOV system, the 
designated germplasm does not actually 
leave the public domain—it continues to be 
available for use. The new combination of 
genes represented by the new cultivar (a 
genotype) is protected, and use of this spe-
cifi c combination is restricted of course, but 
this new combination is different. It is not the 
same as the designated material as received 
from the CGIAR. Its components remain 
available for use, under the same terms as 
before the grant of plant breeder’s rights.
The question of patents—and in particu-
lar, patents on genes—is much more prob-
lematic and worrisome. In the United States, 
for example, patents can be obtained for both 
cultivars and their components. Since passage 
of the U.S. Plant Patent Act of 1930,15 which 
provided patent protection for asexually re-
produced cultivars of domesticated plants 
(such as apple, pear, rose, etc.16), patent or 
patent-like protection has been expanded 
through legislation and court decisions to 
include sexually reproduced plant cultivars,17 
micro-organisms,18 genes and gene com-
plexes,19 characteristics20 and products.21 
Trade secrets, contracts, and use of the tort 
theory of conversion have also been used for 
the protection of plant germplasm.22
In the context of this discussion, cultivar 
patenting causes little distress, as patenting 
of designated material would be prohibited 
under the existing terms of the MTA as cur-
rently interpreted. The question of what the 
14  Typically, lawyers will advise clients against using proprietary products or processes without 
proper authorization in order to avoid any insecurity about title to the fi nal product and the ability 
to use or sell it.
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minimum requirement might be for taking 
out IPRs would still remain, however.
The identifi cation and patenting of a gene 
found in designated material is possible un-
der the laws of a few countries. Such an IPR 
might limit some things that could be done 
with the genetic material in the future. It is 
not clear, however, exactly what limitations 
would arise, in part because this area of pat-
ent law is fl uid and it is diffi cult to predict 
how the laws will be interpreted and enforced 
in the future. At a minimum, such laws would 
prohibit the subsequent, deliberate extraction 
of the genetic material from an accession and 
its targeted use by another party. However, 
will one be allowed to cross an accession 
containing a patented gene with another one, 
moving the gene in more conventional ways? 
The answer appears to be “yes”. Neverthe-
less, further research is needed to assess how 
“gene patenting” might affect use of desig-
nated germplasm and how different defi ni-
tions of “germplasm and related information” 
in the MTA will affect the research (and IPR 
options) of potential recipients of materials 
from the CGIAR Centres and, later, under the 
International Treaty on Plant Genetic Re-
sources. However, one must bear in mind that 
changes in legislation as well as develop-
ments through case-law will alter the poten-
tial impact of this form of IPR on materials 
held “in trust” or available from the Treaty’s 
multilateral system. Further research, while 
warranted, will not provide a defi nitive or 
lasting answer to the questions posed above. 
Political decisions will be needed.
If “germplasm” in the FAO-CGIAR Agree-
ments refers to “accessions”, neither CGIAR 
Centres nor recipients of designated germ-
plasm can claim ownership or seek IPRs over 
that germplasm, that is, over the designated 
accession. This raises the questions: can re-
cipients of designated accessions seek IPR 
protection for components (such as geno-
types, genes, alleles and DNA sequences) of 
those accessions? Can they sequence and 
patent a gene, for example? In a legalistic 
sense, the Agreements and the Joint State-
ments interpreting the Agreements provide 
no unequivocal answer. But the intent of the 
15  Townsend-Parnell Plant Patent Act of 23 May 1930, Public Law No. 245, 71st Congress.
16  These are species which are multiplied asexually for the commercial market by grafting or other 
“cloning” techniques. The Act, however, excludes potato and such tuber crops.
17  Plant Variety Protection Act of 24 December 1970, 84 Stat. 1542, 7 U.S.C. 2321 et seq., as well as 
through Ex Parte Hibberd, 227 U.S.P.Q. 443 (Bd. Pat. App. & Int., 1985).
18  Diamond, Commr. Pats. v. Chakrabarty, 447 U.S. 303, 308–309 (1980).
19  Ex Parte Hibberd, supra, footnote 17.
20  The Federal Circuit Court, in Imazio Nursery v. Dania Greenhouses, 69 F. 3rd 1560 (Fed. Cir., 1995), 
limited the rights of holders of plant patents under the 1930 law to exclude only those who have 
derived their material directly from the patent holder’s stock. Independent creation is thus an 
ample defence in an infringement action. Breeders fashioning a new cultivar with a unique trait—
in this case a heather cultivar that bloomed in different months than other cultivars—must now 
seek protection under utility patent statutes for such a characteristic; see Richard Kjeldgaard and 
David Marsh, Recent United States Developments in Plant Patents, Molecular Breeding, Vol. 2, 1996.
21  Ex Parte Hibberd, supra, footnote 17.
22  See Jeffrey Ihnen and Robert Jondle, Protecting Plant Germplasm: Alternatives to Patent and Plant 
Variety Protection, in Intellectual Property Rights Associated with Plants, American Society of 
Agronomy, Madison, Wisconsin, 1989.
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Agreements is nevertheless evident. Such IPR 
protection runs counter to the goals of the 
Agreements if it results in preventing or re-
stricting the use of the accession.
It must be possible to continue to use all 
accessions held in trust. No institution 
charged with the responsibility of safeguard-
ing genetic diversity for the international 
community would knowingly provide sam-
ples of that diversity for the purpose of fa-
cilitating a recipient’s actions that would 
prevent all others from using the material in 
the future. This could result in those acces-
sions in the public domain simply becoming 
empty shells, devoid of any practical useful-
ness to plant breeders. Such discouragement 
of use would undermine the rationale for 
conservation and jeopardize the very future 
of agriculture. This analysis is offered with 
the understanding that the current MTA and 
the new International Treaty on Plant Ge-
netic Resources both contain language con-
cerning “parts and components” and 
prohibit application of IPRs to these “in the 
form received”.
The question then is not resolved, but it is 
made a bit clearer. Obviously, countries, 
through the Treaty, are expressing the view 
that they want to prohibit some applications 
of IPRs to parts and components. But which 
ones? The answer is contained in the simple, 
but mysterious phrase, “in the form re-
ceived”. Defi ne that phrase and you have 
defi ned what can and cannot be done, in 
terms of IPRs, with parts and components.
Neither the CGIAR nor the international 
community has an interest in discouraging 
research, including that aimed at sequencing 
genes and discovering their uses. Consistent 
with the intent of the FAO-CGIAR Agree-
ments, one could argue that IPR protection 
might be permitted on components of acces-
sions, if the accession itself remained avail-
able for unrestricted use by others, in 
traditional ways such as for crossing.23 Pursu-
ing this train of thought, however, certain 
restrictions aimed at retaining the rights of 
others to use the material might also be 
placed on the seeking of IPRs for components 
of accessions.24
The balance to be struck between keeping 
the material in the public domain and encour-
aging research and innovation can best be 
accomplished if one differentiates between 
the different ways in which a patented gene 
might be used. If a subsequent recipient of 
designated germplasm were free to use mod-
ern technologies to extract and move the 
patented gene (that is, without having to 
honour the patent), this would clearly be a 
devastating disincentive for such research 
involving any designated germplasm. The 
patent would simply provide no protection 
at all and would be irrelevant. However, if 
the patent meant that breeders could no lon-
ger use the accession in crosses, and farmers 
could no longer have and use accessions 
containing the gene, this just as obviously 
would undermine the intent of the Agree-
ments and erode the value of what is now in 
the public domain.25 The goals of the Agree-
ments might best be served if the terms of the 
MTA allowed IPRs on components only in 
cases where innovation was demonstrated 
and only with the guarantee that traditional 
uses of the accession, including cultivation 
and crossing in breeding programmes, could 
continue unhampered.
Assuming that “germplasm” as used in 
the FAO-CGIAR Agreements refers to acces-
sions, the MTA would probably need to be 
amended if the decision were taken that 
components, if protectable at all, would only 
be eligible for IPRs in ways that would not 
23  In the future, however, such disputes will be resolved not by the CGIAR Centres but by the 
Governing Body of the International Treaty on Plant Genetic Resources.
24  This subject is taken up in Section II of this article.
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unduly prohibit their continued use as de-
scribed above.
C. “Related information”
As previously noted, the Agreement between 
the FAO and each CGIAR Centre states that 
the Centre “shall not claim legal ownership 
over the designated germplasm, nor shall 
it seek any intellectual property rights over 
that germplasm or related information.” 
The “information” referred to is information 
related to the designated germplasm. While 
the defi nition of “germplasm” might be open 
to debate, the meaning of the word “informa-
tion” is more certain. The fi rst Joint State-
ment of the FAO and the CGIAR Centres on 
the Agreement Placing CGIAR Germplasm 
Collections Under the Auspices of the FAO 
[Annexe 5] says that:
“The words ‘related information’ at the 
end of Article 3(b) refer to information 
which has been compiled with respect 
to individual accessions. Such informa-
tion includes passport and characteri-
zation data and, when available in the 
databases of the respective genebanks, 
evaluation data and information on 
indigenous knowledge.”26
This wording reinforces the view that 
designated germplasm refers to “accessions”, 
as it specifi es that related information refers 
to “accessions”.
The FAO-CGIAR Agreements, imple-
mented in part through MTAs, require that 
the CGIAR Centres pass on the obligations 
concerning the prohibition on claims of 
ownership and intellectual property rights 
over designated germplasm and related 
information to subsequent recipients. There-
fore, a recipient of “related information” 
from a CGIAR Centre cannot, under the 
terms of the MTA, claim ownership of or 
seek intellectual property rights over that 
related information.
While the spirit of the Agreements is most 
assuredly to keep “related information” (as 
defi ned above) in the public domain, it is not 
clear whether the MTA would oblige a re-
cipient of germplasm to disclose information 
(characterization, evaluation, etc.) that they 
discovered or produced or otherwise place 
such information in the public domain. Prob-
ably not. In the MTA, recipients of desig-
nated germplasm are “requested” to furnish 
the Centre providing the material with “per-
formance data collected during evaluations”. 
The CGIAR will, by policy and by inclination, 
place existing and subsequent related infor-
mation (whether assembled by the Centre or 
provided by subsequent recipients) in the 
public domain under the terms of the FAO-
CGIAR Agreements.
There is a question of “timing”: when does 
“related information” first fall under the 
terms of the FAO-CGIAR Agreements and 
thus under the MTA? Information, such as 
passport and characterization data, gathered 
routinely and properly at the time of collect-
ing and entered into genebank records must 
be considered as falling under the terms of 
the Agreements. This is consistent with the 
requirements of the International Treaty on 
Plant Genetic Resources, which mandates 
access to all available passport information 
and other “associated available non-confi -
dential descriptive information”.
According to the fi rst Joint Statement is-
sued by the FAO and the CGIAR Centres 
[Annexe 5], when evaluation data and infor-
mation on indigenous knowledge are avail-
able in the databases of the genebank, it 
becomes part of the “related information” 
25  The authors know of no patent law that would have such far-reaching effects, however. Patent 
laws applied to such materials are typically restricted to the isolated and purifi ed form of DNA. 
Naturally occurring genes, in their natural form, cannot be patented.
26  First Joint Statement, supra, footnote 3.
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covered by the genebank. This interpretation, 
agreed by the FAO and the CGIAR Centres, 
omits—at least potentially and for a time—
evaluation data and information on indige-
nous knowledge not in the databases of the 
genebanks. The logic behind this is that such 
information may be under development and 
in need of further refi nement or further veri-
fi cation. In the scientifi c community, it would 
be argued that scientists have a right to ex-
plore new ideas and generate data before the 
public interest overrides and dictates that 
they disclose it. Indeed, allowing scientists 
such “freedom” is not just common courtesy; 
it is an incentive for research and thus in the 
public interest. Furthermore, it could be ar-
gued that premature disclosure of research 
results and information by public-sector sci-
entists might facilitate inappropriate privati-
zation by others. As the Joint Statements of 
the FAO and the CGIAR stress, Centres and 
Centre scientists must be allowed to manage 
designated germplasm in keeping with 
sound scientific standards and practices, 
which would include a reasonable period for 
scientists to carry out research and begin 
developing new technologies and products 
prior to publication. This approach represents 
“standard operating procedure” in the 
CGIAR and the public sector in general. This 
approach is also mirrored in the new Treaty 
with regard to the genetic material itself. The 
Treaty provides that access to genetic re-
sources “under development … shall be at 
the discretion of its developer, during the 
period of its development”. Other recipients 
of germplasm, at present, are requested to 
provide information on germplasm back to 
the Centres, but there is no strict legal require-
ment to do so and no expectation that they 
would do this so quickly as to produce a 
disincentive for their own research.
Passport and characterization data are 
typically available in CGIAR genebanks for 
designated accessions. Today, there is little 
need or incentive—or even possibility—to 
claim ownership over such information. 
Evaluation data and indigenous knowledge 
are different matters, involving as they do, 
more research effort and a stronger connec-
tion with commercial activities.
Under the FAO-CGIAR Agreements [An-
nexe 1], Centres (and subsequent recipients) 
cannot claim ownership over the germplasm 
and, in addition, they cannot seek IPRs over 
the germplasm and related information. This 
wording in Article 3 of the Agreements leaves 
Centres and recipients of germplasm free to 
exercise ownership, but not to claim IPRs, 
over certain information associated with the 
germplasm. The FAO-CGIAR Agreements 
allow researchers (including CGIAR research-
ers) to carry out scientifi c research in normal 
and accepted ways. The Agreements do not 
require instant disclosure of all information 
generated through research and testing (such 
as through evaluations). Such a requirement 
would be burdensome, bureaucratic and 
unenforceable and would reduce incentives 
for further research and the publishing of 
useful scientifi c papers. Such research carried 
out by CGIAR Centres will typically enter 
into the public domain, but until that moment 
it may be considered as under development 
and as the property of the Centre. Instant 
disclosure would, in practice, undermine the 
purposes of the FAO-CGIAR Agreements by 
giving critical but unrefi ned and possibly 
even untested, and certainly unexplored, data 
to those who may wish to mine it for propri-
etary purposes.27
It follows from the arguments laid out 
above that information—for example, that a 
high level of resistance to a pest exists within 
a particular accession—should always be-
come part of the public record associated with 
that accession, at least after a period of time 
has elapsed allowing the researcher who 
discovered the trait to use this fi nding before 
declaring it publicly. However, if someone 
later sequences the resistance gene, there 
would be no strict obligation for them to 
make that information public, though they 
would certainly be encouraged to do so.
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D. Summary observations about 
“germplasm and related information”
Currently, CGIAR Centres hold more than 
500,000 accessions of plant genetic resources 
for food and agriculture “in trust” for the 
international community under the auspices 
of the FAO. This “designated germplasm” 
is distributed in large quantities to plant 
breeders and other researchers under the 
terms of an MTA. Centres typically man-
age and distribute the material in the form 
of accessions. It is assumed that the MTA’s 
prohibition against recipients’ acquiring IPRs 
on the “germplasm and related information” 
refers to the accession “as received” from the 
Centre. This practice allows recipients to ac-
cess and use the material with few onerous 
restrictions. It therefore encourages use and 
development of the material while keeping it 
available for use in the future by others.
One could interpret “germplasm” to mean 
all alleles in the designated collections of the 
CGIAR and then prohibit the use of each and 
every allele in a subsequently produced culti-
var. This interpretation would reduce use of 
the materials signifi cantly with dubious posi-
tive consequences. Certain interests might see 
political benefi ts in the exclusion of all genes 
and alleles in the CGIAR collections from fi nal 
protected cultivars. This course of action 
would effectively prevent the collections from 
being used in breeding programmes aimed at 
cultivar protection under the UPOV, a form of 
IPR that does not affect future availability or 
use of the designated accession and a form 
that is becoming increasingly used in both 
developed and developing countries. Any 
interpretation should be judged in the context, 
inter alia, of how it facilitates access and use, 
one of the goals of the Agreements and, in-
deed, of the Convention on Biological Diver-
sity and the International Treaty on Plant 
Genetic Resources for Food and Agriculture.
“Gene patenting”, however, poses a 
unique problem for the handling of “in-trust” 
genetic materials. The possibility exists that 
such IPRs might seriously restrict others from 
accessing and using designated accessions. 
The intent of the FAO-CGIAR Agreements is 
thwarted if such IPRs restrict the future use 
of the accession in traditional breeding pro-
grammes and farmers’ fi elds. More research 
and a careful “watching brief” are needed on 
this subject. Consideration might be given 
both to formulating an operational defi nition 
of “germplasm and related information” and 
to amending the current MTA, or formulating 
the future MTA under the International 
Treaty on Plant Genetic Resources, so as to 
discourage or prevent the application of any 
form of IPR to individual components of 
designated accessions in a way that would 
restrict traditional uses of the accession. It 
should be noted that in this era of genomics, 
gene sequencing has become routine and, in 
and of itself, is largely devoid of what most 
people would consider to be “innovation”. 
Thus, restricting application of IPRs in such 
instances may not adversely affect the real 
innovations that are taking place, not through 
simple sequencing but through assembling 
the “right genes” into usable genotypes.
The term “related information”, as used 
in the FAO-CGIAR Agreements, refers to 
information associated with the designated 
“accession”.28 This includes passport and 
characterization data. It also includes certain 
evaluation data and indigenous knowledge, 
when that information is entered into gene-
bank records. Such an interpretation as-
sumes, of course, that indigenous knowledge 
was acquired properly and that such use is 
allowed. It also assumes that scientists, as 
customary, have had reasonable time to 
verify evaluation data and work with the 
results. Instantaneous disclosure of informa-
27  See C. Fowler, The Status of Public and Proprietary Germplasm and Information: An Assessment of Recent 
Developments at FAO, IP Strategy Today, No. 7, 2003.
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tion is neither practical nor worthwhile in 
scientifi c circles and would serve no purpose 
in the context of the FAO-CGIAR Agree-
ments or the Treaty. Information about the 
sub-accession components of accessions is 
not automatically considered to be part of 
the public domain. Instead, as an incentive 
to research, researchers are given discretion 
in this matter. As a matter of practice, CGIAR 
scientists will continue to place such infor-
mation in the public domain if and when it 
furthers the goals of the CGIAR and aids in 
the development of international public 
goods.
Neither the original FAO-CGIAR Agree-
ments nor the subsequent Joint Statements 
should be interpreted in an overly rigid or 
mechanistic way when it comes to decipher-
ing the meaning of individual phrases such 
as “germplasm and related information”. All 
such phrases in the Agreements come within 
a context—that of advancing the goals of the 
Agreements. The overriding goal is to ensure 
that germplasm, and basic information about 
it, continues to be conserved, managed prop-
erly and made available for scientifi c research 
and plant breeding. Maintaining the sanctity 
of the public domain will be counterproduc-
tive, however, if rules are so rigid as to dis-
courage use. A genebank locked tightly to 
prevent all abuse may as easily prevent all 
use and, in the process, provide no tangible 
benefi t to the public. As in so many realms of 
life, trust and “good faith” are more critical 
to the success of an agreement or treaty than 
the words themselves.
“Trust” alone cannot substitute for an-
swers to legitimate technical questions about 
what can and cannot be done with desig-
nated germplasm, however. Recipients of 
designated germplasm cannot be faulted for 
asking how much (or how little) they must 
do to designated germplasm before they can 
apply for IPR protection within the bounds 
of the MTA. The next Section of this article 
examines this question and looks at alterna-
tives for its resolution.
II. Defi ning a “derivative”: minimum 
requirements for taking out intellectual 
property protection on derivatives of 
designated germplasm
The Agreements signed between the CGIAR 
Centres and the FAO proscribe the taking 
out of IPRs on designated germplasm. This 
material is widely distributed by the Centres, 
and its use, especially in plant breeding, is 
encouraged. However, when designated 
germplasm accessions are used in develop-
ing a new cultivar, the question arises as to 
whether or not the new cultivar derived from 
a designated accession is suffi ciently different 
from the designated accession to be eligible 
for intellectual property protection.
This subject has two elements:
–  what requirements do IPR laws, such as 
UPOV-style plant breeder’s rights laws, 
place on an applicant; and
–  what conditions might a provider of germ-
plasm use in producing a derivative set as 
to how the genetic material can be used 
and/or protected.
Requirements associated with each ele-
ment might be different, refl ecting the differ-
ent needs and goals of the institutions and 
governments involved. This article deals with 
the second of the two elements: the situation 
faced by the CGIAR as a provider of germ-
plasm, including designated germplasm. In 
addressing this element, the authors neither 
make any recommendations nor imply the 
need for changes in the existing UPOV ap-
proach to the subject of derivatives. How the 
UPOV (or any other IPR regime, including 
28  Under the Agreements with the FAO, CGIAR Centres are required to make certain information 
available. This does not prevent them, voluntarily, from making even more information available. 
In other words, the Agreements establish a minimum, not a maximum.
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those involving patenting) deals with this 
issue and how the CGIAR might deal with 
conditions of access to genetic resources, 
while somewhat related, are nevertheless two 
distinct and different issues.
It should be noted that several of the op-
tions presented in this article would have 
the effect of requiring recipients/users of 
germplasm to forego or renounce certain 
rights which might otherwise be available 
to them under applicable IPR laws as a con-
dition for access to and use of the material.29 
Such a “restriction” imposed for access 
would not, of course, contravene IPR stat-
utes. The restrictions, while legally binding, 
would be “voluntary” in the sense that those 
accessing materials from the CGIAR would 
voluntarily agree to be bound to certain 
conditions (restrictions) set forth in an MTA 
as a prerequisite for obtaining and using the 
materials.
The question of derivatives can be ap-
proached from many directions. The intel-
lectual exercise of constructing “reasonable” 
defi nitions based on different approaches is 
a very useful one. At the least, it helps reveal 
the complexity of the issues and lays bare 
those options that are inappropriate, unwork-
able or otherwise problematic. Without going 
through such an exercise in the concrete, it is 
easy to assume that one or another approach 
is workable or even ideal, when in reality it 
might be quite impractical.
The following Sections A through F present 
a series of possible defi nitions of “derivative”, 
each based on a different approach. These 
represent attempts to draft the most reasonable 
defi nition possible for each approach, keeping 
in mind the intentions of the FAO-CGIAR 
Agreements and using language that might 
be appropriate in the associated MTA.
For illustrative purposes, several defi ni-
tions are given for some approaches, present-
ing a range in the ease or diffi culty with which 
the derived material can be made eligible for 
protection. While it might be possible to con-
struct defi nitions based on other criteria (such 
as differences in population means and/or 
variances for “n”, continuously variable 
characters when grown in the same environ-
ment, etc.), defi nitions employing such crite-
ria are likely to become overly complex. In 
many cases, an approach that seems simple, 
straightforward and workable in the abstract 
becomes complicated and problematic when 
one attempts to capture it in legal text as is 
attempted here.
The defi nitions below30 relate solely to the 
protection of plant varieties, whether by 
patents, plant breeder’s rights or other sui 
generis systems.31 They are offered without 
extensive critical commentary—and without 
endorsement—with the intention of engaging 
the reader and encouraging objective consid-
eration and discussion. It may well be that 
most readers will fi nd most of the individual 
options lacking in some respect or another. 
While the approaches represented in Options 
A through D may seem reasonable or attrac-
tive “in theory”, it is to be expected that upon 
examining a text embodying the approach, 
the reader will judge each to be unsuitable 
for various scientifi c and practical reasons. 
Option “E” describes several “composite” 
defi nitions constructed by using combina-
tions of different approaches in an attempt to 
29  It should be noted that the MTA currently in use in the CGIAR also imposes certain restrictions 
and conditions, albeit ones that are not easy to interpret with precision.
30  The discussion below excludes issues related to cytoplasmic diversity.
31  The situation (as it applies to CGIAR scientists) with respect to the protection of genes, gene 
constructs, organelles, etc. identifi ed within, or based on studies of, designated germplasm 
is already covered in the CGIAR IPR Guidelines, and a further option of how to deal with 
components of designated germplasm is provided in this article.
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overcome some of the limitations of indi-
vidual approaches.
Option “F” describes an option that arises 
from the view that the goal of any defi nition 
is not to set a mechanical or arbitrary require-
ment for derivatives (as certain IPR regimes 
might do, in effect) but to facilitate access 
while ensuring “availability for use” by fu-
ture recipients and users of germplasm. It is 
drafted to cover varieties, gene constructs, 
cell lines, etc. The reader’s attention is drawn 
to this option, in particular, as worthy of 
critical attention.
A. Defi nitions based on allelic differences
1)  “To be eligible for intellectual property 
protection, the derived material must 
differ by one (or any other arbitrary num-
ber) or more alleles from any individual 
designated accession in its parentage.”
2)  “To be eligible for intellectual property 
protection, the derived material must dif-
fer by a signifi cant number of alleles from 
any individual designated accession in its 
parentage.”
Note:
–  Defi nition A.1 would allow designated 
material having just the addition of a 
single gene (e.g. through genetic engi-
neering) or substitute allele (e.g. through 
back-crossing) to be eligible for IPR 
 protection.
–  Definition A.2, while difficult or im-
possible to quantify—and hence apply 
legally—nevertheless gives perhaps a 
better feel for the intent of the prohibi-
tion against IPR protection of designated 
germplasm. It might be desirable to 
combine both elements in a defi nition 
such as:
“To be eligible for intellectual prop-
erty protection, the derived mate-
rial must differ signifi cantly, and by 
a minimum of 4 alleles, from any 
individual designated accession in 
its parentage.”32
B. Defi nitions based on allelic frequencies
“To be eligible for intellectual property pro-
tection, the allelic frequency of at least one 
allele (or any other arbitrary number) in the 
derived material must differ from that in any 
individual designated accession in its parent-
age by more than X percent.”33
Note:
–  A defi nition such as this might be more 
appropriate for cross-pollinated species 
and heterogeneous populations.
–  Allelic frequencies are diffi cult to measure 
and monitor.
–  This defi nition would enable the results 
of single plant or mass-selection within 
a single designated germplasm accession 
to become eligible for protection (assum-
ing it met the criteria of the relevant IPR 
law).
32  DNA marker-aided analysis of genetic variation among hybrids, lines or clones provides a means for 
determining how distinct two accessions or cultivars are from one another. A core number of DNA 
markers per each linkage group of the crop species is needed. Christiansen et al. provide a fi gure 
of the DNA “picture” for such an assessment; see M.J. Christiansen, S.B. Andersen and R. Ortiz, 
Diversity Changes in an Intensively Bred Wheat Germplasm during the 20th Century, Molecular Breeding 
9, 2002, at 1–11. Likewise, Lund et al. show the methods needed to determine the original source of an 
accession using germplasm repatriation as an example: see B. Lund, R. Ortiz, I. Skovgaard, R. Waugh 
and S.B. Andersen, Analysis of Potential Duplicates in Barley Gene Bank Collections Using Re-sampling of 
Microsatellite Data, Theoretical and Applied Genetics 106, 2003, at 1129–1138.
33  The greater the percentage, the greater the changes that have to be made before a derivative is eligible 
for IPRs. Allelic frequency should be expressed in a different way for polysomic polyploid species.
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C. Defi nitions based on phenotype
“To be eligible for intellectual property 
protection, the derived material must differ 
from any individual designated accession in 
its parentage by one (or any other arbitrary 
number) or more traits.”34
Note:
–  To avoid “cosmetic” breeding situations, 
the definition could indicate “useful 
traits” or “traits of agronomic, nutritional 
or economic signifi cance”. Thus, for ex-
ample, in a fuller form, defi nition C could 
read:
“To be eligible for intellectual 
property protection, the derived 
material must differ from any in-
dividual designated accession in its 
parentage by one or more traits of 
agronomic, nutritional or economic 
signifi cance, each having a (nar-
row-sense-) heritability exceeding 
0.75 (or a different fi gure).”
D. Defi nitions based on breeding action
1)  “To be eligible for intellectual property 
protection, the derived material must, at 
a minimum, be the result of single plant 
or mass-selection within a designated 
accession.”
2)  “To be eligible for intellectual property 
protection, the derived material must 
be the result of at least one (or any other 
arbitrary number) hybridization among 
designated accessions or between desig-
nated and non-designated material.”
Note:
–  Either of the following could be added to 
each of the defi nitions:
(i) “The addition of one or more specifi c 
genes, e.g. through gene transforma-
tion, also confers eligibility for protec-
tion.”
(ii) “The addition of one or more specifi c 
genes, e.g. through gene transforma-
tion, does not confer eligibility for 
protection.”
–  In addition, the following could, as ap-
propriate, be added to a version of D.2:
“However, the addition of a single 
gene or allele to a designated acces-
sion, e.g. through back-crossing or 
other techniques, is not suffi cient to 
confer eligibility.”
– These defi nitions, while relatively straightfor-
ward and easy to put into practice, would be 
diffi cult to monitor for compliance.
E. Composite defi nitions
It is obviously possible to construct a very 
large number of composite defi nitions35 based 
on the above. For example:
1)  Breeding Action + Phenotype: “To be eligible 
for intellectual property protection, the 
plant entity or derived material must be 
a genetic innovation ensuing from human 
selection after gene re-assortments result-
ing from meiosis. Such an entity should be 
a distinct genotype in an arbitrary number 
of loci (accounting for in excess of 75 per-
cent of trait variation) from both parental 
34  A phenotypic index ensuing from quantitative trait data provides some measurement of relatedness 
between the original source and derivatives, as shown by Ortiz et al. for Nordic spring wheat and 
barley. Both crop species are self-pollinated species with disomic inheritance. An arbitrary number 
of DNA markers per chromosome arm that account for in excess of 75 percent of (quantitative) 
trait variation may assist in this endeavour. The number of DNA markers will depend on species’ 
breeding system. See R. Ortiz, S. Madsen and S.B. Andersen, Diversity in Nordic Spring Wheat 
Cultivars (1901-1993), Acta Agriculturæ Scandinavica (Section B Soil and Plant Sciences) 48, 1998, at 
229–238; and R. Ortiz, M. Nurminiemi, S. Madsen, O.A. Rognli and Å. Bjørnstad, Cultivar Diversity in 
Nordic Spring Barley Breeding (1930-1991), Euphytica 123, 2002, at 111–119.
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sources and any other known accession 
in the gene pool.”
2)  Breeding Action + Allelic Difference: “To 
be eligible for intellectual property pro-
tection, the derived material must be 
the result of at least four hybridizations 
among designated accessions or between 
designated and non-designated material. 
However, the addition of a single gene or 
allele to a designated accession, through 
backcrossing or other techniques, is not 
suffi cient to confer eligibility. In addition, 
the derived material must differ by six or 
more alleles from any individual desig-
nated accession in its parentage.”
3)  Breeding Action + Allelic Frequency: “To 
be eligible for intellectual property pro-
tection, the derived material must be 
the result of at least two hybridizations 
among designated accessions, or between 
designated and non-designated material, 
and/or the allelic frequency of at least 
two alleles in the derived material must 
differ from that in any of the individual 
designated accessions in its parentage by 
more than 25 percent.”
4)  Allelic Frequency + Phenotype: “To be eli-
gible for intellectual property protection, 
the allelic frequency of at least one allele in 
the derived material must differ from that 
in any individual designated accession 
in its parentage by more than 25 percent 
and must differ from the individual des-
ignated accession in its parentage by one 
or more traits of high heritability.”
5)  Mechanical + Phenotype: “To be eligible 
for intellectual property protection, the 
derived material must be the result of at 
least one hybridization among designated 
accessions or between designated and 
non-designated material. In addition, 
the derived material must differ from 
any individual designated accession in 
its parentage by one or more traits of 
deemed commercial value. The addition 
of a single gene or allele to a designated 
accession, through back-crossing or other 
techniques such as genetic engineering, 
the selection of a natural or induced mu-
tant, or of a somaclonal variant, or the 
selection of a variant individual from a 
designated accession, is not suffi cient to 
confer  eligibility.”
F. Defi nitions based on availability for use 
of designated germplasm
An alternative approach would be to employ 
a defi nition which, while allowing for IPRs, 
aims to ensure that the designated accession 
or the designated accession and its com-
ponents remain available for use by other 
recipients in defi ned ways. The goal of this 
approach would be to keep the material in the 
public domain while encouraging research on 
designated accessions. Possible provisions 
incorporating this approach might include:
1)  “The recipient of designated germplasm 
is not prevented from taking out intel-
lectual property protection on any new 
cultivar, gene construct, cell line or other 
component of the material identifi ed or 
developed as a result of their research 
on or with the germplasm, providing the 
designated material and its components 
remain within the public domain and 
continue to be available for further use 
without restriction.”
2)  “The recipient of designated germplasm is 
not prevented from taking out intellectual 
property protection on any new cultivar, 
gene construct, cell line or other compo-
nent of the material invented through 
35  Particular requirement levels (e.g. differing in parentage by more than 25 percent, the result of 
at least four hybridizations, etc.) are offered as reasonable requirements within the context of the 
approach but are still simply illustrative. Different requirement levels could be substituted for 
those contained herein.
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their research on or with the germplasm, 
providing the designated accession re-
mains available for use without restric-
tion, and its components remain available 
for use through traditional means such as 
hybridizing, selection, etc.”
3)  “The recipient of designated germplasm 
is not prevented from taking out intel-
lectual property protection on any new 
cultivar, gene construct, cell line or other 
component of the designated material 
identifi ed or developed as a result of in-
vention from their research on or with 
the in-trust germplasm, providing the 
germplasm and its components remain 
in trust with the CGIAR Centre for the 
benefi t of all humanity, within the public 
domain and available for any future use 
without restriction.”
To any of the options under “F” might be 
added the following provision:
“The applicant will undertake to dis-
close relevant accessions as received 
to the Offi ce granting the rights and 
admit them to be ‘prior art’, in the 
face of which the protectable advance 
should be judged.”
This addition would acknowledge the 
contribution of designated material and place 
on record the applicant’s recognition that 
his/her “invention” must be judged as new 
specifi cally in relation to materials in the 
public domain. In cases where IPRs might be 
challenged, such a requirement would bolster 
the position of the CGIAR Centres in their 
efforts to ensure that the spirit of the FAO-
CGIAR Agreements is upheld.
Note:
–  Defi nition F.1 would allow for patenting 
of components, though under somewhat 
restrictive conditions. For example, when 
a gene is identifi ed and used together with 
a promoter, the total construct might be 
patentable. The original gene, however, 
would still be fully available as before—in 
the original material, for example—for use 
in conventional breeding or even for use 
in a different construct. Another example 
might be when a gene is identifi ed but 
could be patented only for use in species 
other than the parental one.
–  Defi nition F.2 employs slightly different 
wording and a slightly more relaxed ap-
proach to IPR protection. Both provisions 
might require the applicant for IPRs to re-
nounce certain rights typically granted by 
government authorities through patents. 
The recipient of designated germplasm 
would presumably be made aware of this 
situation upon transfer of the designated 
germplasm and would be able to make a 
voluntary decision as to whether he/she 
wished to obtain the designated material 
under the stated conditions.
Concluding remarks
The FAO and the CGIAR Centres have 
fashioned a unique relationship in which 
the Centres are entrusted with the conserva-
tion, management, use and distribution of a 
signifi cant portion of the world’s biological 
diversity of economically important crops. 
This material is held “in trust” by the Centres 
for the international community. That com-
munity has an interest in seeing it remain 
available for all to use. It also has an interest 
in encouraging the development and use of 
these genetic resources.
Rules governing access and use must be 
transparent. Potential users must know what 
exactly is “publicly” available. They need 
also to understand what exactly they can do 
with the material and what they cannot do, 
including whether and under what circum-
stances IPRs might be sought for materials 
derived from designated germplasm. This 
article has sought to bring clarity to these 
issues by proposing how the “germplasm 
and related information” covered by the 
FAO-CGIAR Agreements should be inter-
preted and by describing a number of op-
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tions for minimum requirements for taking 
out intellectual property protection on de-
rivatives and components of designated 
germplasm. The FAO, the CGIAR and the 
international community may choose not to 
accept any of these options. Indeed, they 
may choose to retain the status quo in which 
the question of what can and cannot be done 
with designated germplasm is left unan-
swered. Choosing not to deal with the sub-
ject is itself a choice, though perhaps not the 
best one. Rather than proposing a particular 
“solution,” this article is offered with the aim 
of encouraging discussion, intentionality 
and transparency.
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Annexe 1: The Agreement Between [name of Centre] and the Food and Agri-
culture Organization of the United Nations (FAO) Placing Collections of Plant 
Germplasm under the Auspices of FAO
Preamble
The [Name of Centre] (hereinafter referred to 
as the “Centre”), supported by the Consulta-
tive Group on International Agricultural Re-
search (hereinafter referred to as “CGIAR”), 
and the Food and Agriculture Organization 
of the United Nations (hereinafter referred 
to as “FAO”);
Considering the importance to humanity of 
protecting and conserving plant germplasm 
for future generations;
Considering the International Undertaking 
on Plant Genetic Resources adopted by the 
FAO Conference at its Twenty-second Session 
in 1983 (Resolution 8/83) and in particular 
Article 7 thereof: and the Annexes of the 
Undertaking adopted by the FAO Conference 
in 1989 and 1991;
Considering that the FAO Commission 
on Plant Genetic Resources (hereinafter 
referred to as the “Commission”), as the 
relevant intergovernmental body in this 
fi eld, has the responsibility for monitoring 
of the implementation of Article 7 of the 
International Undertaking on Plant Genetic 
Resources;
Considering the Memorandum of Under-
standing Between the Food and Agriculture 
Organization of the United Nations and the 
International Board for Plant Genetic Re-
sources (IBPGR) dated September 21, 1990, on 
the respective roles of the two organizations 
in establishing, maintaining and managing 
germplasm collections and setting standards 
for these collections;
Considering the strong support FAO, as one of 
the co-sponsors, has provided and continues 
to provide to the CGIAR;
Considering the importance of the plant germ-
plasm collections held by the Inter national 
Agriculture Research Centres (IARCs), 
 supported by the CGIAR, as part of the global 
strategy for germplasm conservation;
Considering that the CGIAR adheres to a pol-
icy on plant genetic resources which is based 
on the unrestricted availability of germplasm 
held in their genebanks;
Considering that the germplasm accession 
have been donated or collected on the 
understanding that these accessions will 
remain freely available and that they will be 
conserved and used in research on behalf of 
the international community, in particular the 
developing countries;
Considering that the Centre has expressed the 
wish that its designated germplasm be rec-
ognized as part of the international network 
of ex situ collection (as per the International 
Undertaking on Plant Genetic Resources) 
under the auspices of FAO;
Have agreed as follows:
Article 1: Application of this agreement
This Agreement shall be construed and 
applied in a manner consistent with the 
provisions of the Convention on Biological 
Diversity and the International Undertaking 
on Plant Genetic Resources.
Article 2: Basic undertaking
The Centre hereby places under the auspices 
of FAO, as part of the international network 
of ex situ collections provided for in Article 
7 of the International Undertaking on Plant 
Genetic Resources, the collections of plant ge-
netic resources listed in the Appendix hereto 
(hereinafter referred to as the “designated 
germplasm”), as catalogued and published 
by the Centre in print or machine-readable 
form, in accordance with the terms and con-
ditions set forth in this Agreement. The list 
of designated germplasm will be updated 
every two years as new accessions are added 
to the collection.
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Article 3: Status of designated germplasm
(a) The Centre shall hold the designated 
germplasm in trust for the benefi t of the 
international community, in particular the 
developing countries in accordance with 
the International Undertaking on Plant 
Genetic Resources and the terms and 
conditions set out in this Agreement. 
(b) The Centre shall not claim legal owner-
ship over the designated germplasm, 
nor shall it seek any intellectual property 
rights over that germplasm or related 
information.
Article 6: Policies
The Centre recognizes the intergovernmental 
authority of FAO and its Commission in set-
ting policies for the International Network 
referred to in Article 7 of the International 
Undertaking and undertakes to consult with 
FAO and its Commission on proposed policy 
changes related to the conservation of, or 
accessibility to, the designated germplasm, 
subject, always, to the provisions of Article 
9 hereinafter. The Centre shall give full con-
sideration to any policy changes proposed by 
the Commission.
Article 9: Availability of designated 
germplasm and related information
The Centre undertakes to make samples of 
the designated germplasm and related infor-
mation available directly to users or through 
FAO, for the purpose of scientifi c research, 
plant breeding or genetic resources conserva-
tion, without restriction.
Article 10: Transfer of designated 
germplasm and related information
Where samples of the designated germplasm 
and/or related information are transferred 
to any other person or institution, the Cen-
tre shall ensure that such other person or 
institution, and any further entity receiving 
samples of the designated germplasm from 
such person or institution, are bound by the 
conditions set out in Article 3 (b) and, in the 
case of samples duplicated for safety pur-
poses, to the provisions of Article 5 (a).
This provision shall not apply to the repa-
triation of germplasm to the country that 
provided such germplasm.
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Annexe 2: Relevant parts of the International Treaty on Plant Genetic 
Resources For Food And Agriculture
Preamble
The Contracting Parties,
Convinced of the special nature of plant ge-
netic resources for food and agriculture, their 
distinctive features and problems needing 
distinctive solutions;
Alarmed by the continuing erosion of these 
resources;
Cognizant that plant genetic resources for food 
and agriculture are a common concern of all 
countries, in that all countries depend very 
largely on plant genetic resources for food 
and agriculture that originated elsewhere;
Acknowledging that the conservation, explora-
tion, collection, characterization, evaluation 
and documentation of plant genetic resources 
for food and agriculture are essential in 
meeting the goals of the Rome Declaration 
on World Food Security and the World Food 
Summit Plan of Action and for sustainable 
agricultural development for this and future 
generations, and that the capacity of develop-
ing countries and countries with economies 
in transition to undertake such tasks needs 
urgently to be reinforced;
Noting that the Global Plan of Action for the 
Conservation and Sustainable Use of Plant 
Genetic Resources for Food and Agriculture 
is an internationally agreed framework for 
such activities;
Acknowledging further that plant genetic 
resources for food and agriculture are the 
raw material indispensable for crop genetic 
improvement, whether by means of farmers’ 
selection, classical plant breeding or modern 
biotechnologies, and are essential in adapting 
to unpredictable environmental changes and 
future human needs;
Affi rming that the past, present and future 
contributions of farmers in all regions of the 
world, particularly those in centres of origin 
and diversity, in conserving, improving and 
making available these resources, is the basis 
of Farmers’ Rights;
Affi rming also that the rights recognized in this 
Treaty to save, use, exchange and sell farm-
saved seed and other propagating material, 
and to participate in decision-making regard-
ing, and in the fair and equitable sharing of 
the benefi ts arising from, the use of plant 
genetic resources for food and agriculture, 
are fundamental to the realization of Farmers’ 
Rights, as well as the promotion of Farmers’ 
Rights at national and international levels;
Recognizing that this Treaty and other inter-
national agreements relevant to this Treaty 
should be mutually supportive with a view to 
sustainable agriculture and food security;
Affi rming that nothing in this Treaty shall be 
interpreted as implying in any way a change 
in the rights and obligations of the Contracting 
Parties under other international agreements;
Understanding that the above recital is not 
intended to create a hierarchy between this 
Treaty and other international agreements;
Aware that questions regarding the manage-
ment of plant genetic resources for food and 
agriculture are at the meeting point between 
agriculture, the environment and commerce, 
and convinced that there should be synergy 
among these sectors;
Aware of their responsibility to past and 
future generations to conserve the World’s 
diversity of plant genetic resources for food 
and agriculture;
Recognizing that, in the exercise of their sover-
eign rights over their plant genetic resources 
for food and agriculture, states may mutu-
ally benefi t from the creation of an effective 
multilateral system for facilitated access to a 
negotiated selection of these resources and for 
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the fair and equitable sharing of the benefi ts 
arising from their use; and
Desiring to conclude an international agree-
ment within the framework of the Food and 
Agriculture Organization of the United Na-
tions, hereinafter referred to as FAO, under 
Article XIV of the FAO Constitution;
Have agreed as follows:
PART I – INTRODUCTION
Article 1 – Objectives
1.1 The objectives of this Treaty are the con-
servation and sustainable use of plant 
genetic resources for food and agricul-
ture and the fair and equitable sharing 
of the benefi ts arising out of their use, 
in harmony with the Convention on 
Biological Diversity, for sustainable 
agriculture and food security.
1.2 These objectives will be attained by 
closely linking this Treaty to the Food 
and Agriculture Organization of the 
United Nations and to the Convention 
on Biological Diversity.
Article 2 – Use of terms
For the purpose of this Treaty, the following 
terms shall have the meanings hereunder 
assigned to them. These defi nitions are not 
intended to cover trade in commodities:
“In situ conservation” means the conservation 
of ecosystems and natural habitats and the 
maintenance and recovery of viable popula-
tions of species in their natural surroundings 
and, in the case of domesticated or cultivated 
plant species, in the surroundings where they 
have developed their distinctive properties.
“Ex situ conservation” means the conserva-
tion of plant genetic resources for food and 
agriculture outside their natural habitat.
“Plant genetic resources for food and agri-
culture” means any genetic material of plant 
origin of actual or potential value for food 
and agriculture.
“Genetic material” means any material of 
plant origin, including reproductive and 
vegetative propagating material, containing 
functional units of heredity.
“Variety” means a plant grouping, within a 
single botanical taxon of the lowest known 
rank, defi ned by the reproducible expres-
sion of its distinguishing and other genetic 
characteristics.
“Ex situ collection” means a collection of plant 
genetic resources for food and agriculture 
maintained outside their natural habitat.
“Centre of origin” means a geographical 
area where a plant species, either domesti-
cated or wild, fi rst developed its distinctive 
properties.
“Centre of crop diversity” means a geograph-
ic area containing a high level of genetic di-
versity for crop species in in situ conditions.
Article 3 – Scope
This Treaty relates to plant genetic resources 
for food and agriculture.
PART II - GENERAL PROVISIONS
Article 4 - General Obligations
Each Contracting Party shall ensure the 
conformity of its laws, regulations and pro-
cedures with its obligations as provided in 
this Treaty.
PART III - FARMERS’ RIGHTS
Article 9 – Farmers’ Rights
9.1 The Contracting Parties recognize the 
enormous contribution that the local and 
indigenous communities and farmers of 
all regions of the world, particularly those 
in the centres of origin and crop diversity, 
have made and will continue to make for 
the conservation and development of 
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plant genetic resources which constitute 
the basis of food and agriculture produc-
tion throughout the world.
9.2  The Contracting Parties agree that the 
responsibility for realizing Farmers’ 
Rights, as they relate to plant genetic 
resources for food and agriculture, 
rests with national governments. In 
accordance with their needs and priori-
ties, each Contracting Party should, as 
 appropriate, and subject to its national 
legislation, take measures to protect and 
promote Farmers’ Rights, including:
(a) protection of traditional knowledge 
relevant to plant genetic resources 
for food and agriculture;
(b) the right to equitably participate in 
sharing benefits arising from the 
utilization of plant genetic resources 
for food and agriculture; and
(c) the right to participate in making 
decisions, at the national level, on 
matters related to the conservation 
and sustainable use of plant genetic 
resources for food and agriculture.
9.3  Nothing in this Article shall be inter-
preted to limit any rights that farm-
ers have to save, use, exchange and 
sell farm-saved seed/propagating 
 material, subject to national law and 
as appropriate.
PART IV - THE MULTILATERAL SYSTEM 
OF ACCESS AND BENEFIT-SHARING
Article 10 – Multilateral System of Access 
and Benefi t-sharing
10.1 In their relationships with other States, 
the Contracting Parties recognize the 
sovereign rights of States over their own 
plant genetic resources for food and 
agriculture, including that the authority 
to determine access to those resources 
rests with national governments and is 
subject to national legislation.
10.2 In the exercise of their sovereign rights, 
the Contracting Parties agree to es-
tablish a multilateral system, which 
is effi cient, effective, and transparent, 
both to facilitate access to plant genetic 
resources for food and agriculture, and 
to share, in a fair and equitable way, the 
benefi ts arising from the utilization of 
these resources, on a complementary 
and mutually reinforcing basis.
Article 11 – Coverage of the Multilateral 
System
11.1 In furtherance of the objectives of con-
servation and sustainable use of plant 
genetic resources for food and agricul-
ture and the fair and equitable sharing of 
benefi ts arising out of their use, as stated 
in Article 1, the Multilateral System shall 
cover the plant genetic resources for 
food and agriculture listed in Annex I, 
established according to criteria of food 
security and interdependence.
11.2 The Multilateral System, as identifi ed in 
Article 11.1, shall include all plant genetic 
resources for food and agriculture listed in 
Annex I that are under the management 
and control of the Contracting Parties 
and in the public domain. With a view to 
achieving the fullest possible coverage of 
the Multilateral System, the Contracting 
Parties invite all other holders of the plant 
genetic resources for food and agriculture 
listed in Annex I to include these plant 
genetic resources for food and agriculture 
in the Multilateral System.
11.3 Contracting Parties also agree to take 
appropriate measures to encourage 
natural and legal persons within their 
jurisdiction who hold plant genetic re-
sources for food and agriculture listed 
in Annex I to include such plant genetic 
resources for food and agriculture in the 
Multilateral System.
11.4 Within two years of the entry into force 
of the Treaty, the Governing Body shall 
assess the progress in including the 
plant genetic resources for food and 
 agriculture referred to in paragraph 11.3 
in the Multilateral System.  Following this 
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assessment, the Governing Body shall 
decide whether access shall continue to 
be facilitated to those natural and legal 
persons referred to in paragraph 11.3 that 
have not included these plant genetic 
resources for food and agriculture in the 
Multilateral System, or take such other 
measures as it deems appropriate.
11.5 The Multilateral System shall also in-
clude the plant genetic resources for 
food and agriculture listed in Annex 
I and held in the ex situ collections of 
the International Agricultural Research 
Centres of the Consultative Group on 
International Agricultural Research 
(CGIAR), as provided in Article 15.1a, 
and in other international institutions, 
in accordance with Article 15.5.
Article 12 – Facilitated access to plant 
genetic resources for food and agriculture 
within the Multilateral System
12.1 The Contracting Parties agree that 
facilitated access to plant genetic re-
sources for food and agriculture under 
the Multilateral System, as defi ned in 
Article 11, shall be in accordance with 
the provisions of this Treaty.
12.2 The Contracting Parties agree to take 
the necessary legal or other appropri-
ate measures to provide such access to 
other Contracting Parties through the 
Multilateral System. To this effect, such 
access shall also be provided to legal and 
natural persons under the jurisdiction 
of any Contracting Party, subject to the 
provisions of Article 11.4.
12.3 Such access shall be provided in accord-
ance with the conditions below:
(a) Access shall be provided solely for 
the purpose of utilization and con-
servation for research, breeding and 
training for food and agriculture, 
provided that such purpose does not 
include chemical, pharmaceutical 
and/or other non-food/feed indus-
trial uses. In the case of multiple-use 
crops (food and non-food), their 
importance for food security should 
be the determinant for their inclusion 
in the Multilateral System and avail-
ability for facilitated access.
(b) Access shall be accorded expedi-
tiously, without the need to track indi-
vidual accessions and free of charge, 
or, when a fee is charged, it shall not 
exceed the minimal cost involved;
(c) All available passport data and, 
subject to applicable law, any other 
associated available non-confi den-
tial descriptive information, shall 
be made available with the plant 
genetic resources for food and agri-
culture provided;
(d) Recipients shall not claim any intel-
lectual property or other rights that 
limit the facilitated access to the 
plant genetic resources for food and 
agriculture, or their genetic parts or 
components, in the form received 
from the Multilateral System;
(e) Access to plant genetic resources for 
food and agriculture under devel-
opment, including material being 
developed by farmers, shall be at the 
discretion of its developer, during 
the period of its development;
(f) Access to plant genetic resources for 
food and agriculture protected by 
intellectual and other property rights 
shall be consistent with relevant 
international agreements, and with 
relevant national laws;
(g) Plant genetic resources for food and 
agriculture accessed under the Mul-
tilateral System and conserved shall 
continue to be made available to the 
Multilateral System by the recipients 
of those plant genetic resources for 
food and agriculture, under the 
terms of this Treaty; and
(h) Without prejudice to the other pro-
visions under this Article, the Con-
tracting Parties agree that access to 
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plant genetic resources for food and 
agriculture found in in situ condi-
tions will be provided according to 
national legislation or, in the absence 
of such legislation, in accordance 
with such standards as may be set 
by the Governing Body.
12.4 To this effect, facilitated access, in accord-
ance with Articles 12.2 and 12.3 above, 
shall be provided pursuant to a stand-
ard material transfer agreement (MTA), 
which shall be adopted by the Governing 
Body and contain the provisions of Ar-
ticles 12.3a, d and g, as well as the ben-
efi tsharing provisions set forth in Article 
13.2d(ii) and other relevant provisions 
of this Treaty, and the provision that the 
recipient of the plant genetic resources 
for food and agriculture shall require that 
the conditions of the MTA shall apply to 
the transfer of plant genetic resources for 
food and agriculture to another person 
or entity, as well as to any subsequent 
transfers of those plant genetic resources 
for food and agriculture.
12.5 Contracting Parties shall ensure that an 
opportunity to seek recourse is avail-
able, consistent with applicable juris-
dictional requirements, under their legal 
systems, in case of contractual disputes 
arising under such MTAs, recognizing 
that obligations arising under such 
MTAs rest exclusively with the parties 
to those MTAs.
12.6 In emergency disaster situations, the 
Contracting Parties agree to provide 
facilitated access to appropriate plant ge-
netic resources for food and agriculture 
in the Multilateral System for the purpose 
of contributing to the re-establishment of 
agricultural systems, in cooperation with 
disaster relief co-ordinators.
Article 13 - Benefi t-sharing in the 
Multilateral System
13.1 The Contracting Parties recognize that 
facilitated access to plant genetic re-
sources for food and agriculture which 
are included in the Multilateral System 
constitutes itself a major benefi t of the 
Multilateral System and agree that ben-
efi ts accruing therefrom shall be shared 
fairly and equitably in accordance with 
the provisions of this Article.
13.2 The Contracting Parties agree that ben-
efi ts arising from the use, including 
commercial, of plant genetic resources 
for food and agriculture under the 
Multilateral System shall be shared 
fairly and equitably through the fol-
lowing mechanisms: the exchange of 
information, access to and transfer of 
technology, capacity-building, and the 
sharing of the benefi ts arising from 
commercialization, taking into ac-
count the priority activity areas in the 
rolling Global Plan of Action, under 
the guidance of the Governing Body:
(a) Exchange of information:
 The Contracting Parties agree to 
make available information which 
shall, inter alia, encompass cata-
logues and inventories, information 
on technologies, results of techni-
cal, scientific and socio-economic 
research, including characterization, 
evaluation and utilization, regard-
ing those plant genetic resources for 
food and agriculture under the Multi-
lateral System. Such information 
shall be made available, where non-
confi dential, subject to applicable 
law and in accordance with national 
capabilities. Such information shall 
be made available to all Contracting 
Parties to this Treaty through the 
information system, provided for in 
Article 17.
(b) Access to and transfer of technology
(i) The Contracting Parties under-
take to provide and/or facilitate 
access to technologies for the 
conservation, characterization, 
evaluation and use of plant 
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genetic resources for food and 
agriculture which are under the 
Multilateral System. Recognizing 
that some technologies can only 
be transferred through genetic 
material, the Contracting Parties 
shall provide and/or facilitate 
access to such technologies and 
genetic material which is under 
the Multilateral System and to 
improved varieties and genetic 
material developed through the 
use of plant genetic resources for 
food and agriculture under the 
Multilateral System, in conform-
ity with the provisions of Article 
12. Access to these technologies, 
improved varieties and genetic 
material shall be provided and/
or facilitated, while respecting 
applicable property rights and 
access laws, and in accordance 
with national capabilities.
(ii) Access to and transfer of technol-
ogy to countries, especially to 
developing countries and coun-
tries with economies in transition, 
shall be carried out through a set 
of measures, such as the estab-
lishment and maintenance of, 
and participation in, crop-based 
thematic groups on utilization 
of plant genetic resources for 
food and agriculture, all types 
of partnership in research and 
development and in commercial 
joint ventures  relating to the ma-
terial received, human resource 
development, and effective ac-
cess to research facilities.
(iii) Access to and transfer of technol-
ogy as referred to in (i) and (ii) 
above, including that protected 
by intellectual property rights, 
to developing countries that are 
Contracting Parties, in particular 
least developed countries, and 
countries with economies in tran-
sition, shall be provided and/or 
facilitated under fair and most 
favourable terms, in particular in 
the case of technologies for use in 
conservation as well as technolo-
gies for the benefi t of farmers in 
developing countries, especially 
in least developed countries, 
and countries with economies 
in transition, including on con-
cessional and preferential terms 
where mutually agreed, inter alia, 
through partnerships in research 
and development under the 
 Multilateral System. Such access 
and transfer shall be provided on 
terms which recognize and are 
consistent with the adequate and 
effective protection of intellectual 
property rights.
(c) Capacity-building
 Taking into account the needs of de-
veloping countries and countries with 
economies in transition, as expressed 
through the priority they accord to 
building capacity in plant genetic 
resources for food and agriculture in 
their plans and programmes, when 
in place, in respect of those plant 
genetic resources for food and agri-
culture covered by the Multilateral 
System, the Contracting Parties agree 
to give priority to (i) establishing 
and/or strengthening programmes 
for scientific and technical educa-
tion and training in conservation 
and sustainable use of plant genetic 
resources for food and agriculture, (ii) 
developing and strengthening facili-
ties for conservation and sustainable 
use of plant genetic resources for 
food and agriculture, in particular in 
developing countries, and countries 
with economies in transition, and 
(iii) carrying out scientifi c research 
preferably, and where possible, in 
developing countries and countries 
with economies in transition, in co-
operation with institutions of such 
countries, and developing capacity 
for such research in fi elds where they 
are needed.
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(d) Sharing of monetary and other 
 benefi ts of commercialization
(i) The Contracting Parties agree, 
under the Multilateral System, 
to take measures in order to 
achieve commercial benefit-
 sharing, through the involve-
ment of the private and public 
sectors in activities identifi ed 
under this Article, through 
partnerships and collabora-
tion, including with the private 
sector in developing countries 
and countries with economies 
in transition, in research and 
technology development;
(ii) The Contracting Parties agree that 
the standard Material Transfer 
Agreement referred to in Article 
12.4 shall include a requirement 
that a recipient who commer-
cializes a product that is a plant 
genetic resource for food and 
agriculture and that incorporates 
material accessed from the Mul-
tilateral System, shall pay to the 
mechanism referred to in Article 
19.3f, an equitable share of the 
benefi ts arising from the commer-
cialization of that product, except 
whenever such a product is avail-
able without restriction to others 
for further research and breeding, 
in which case the recipient who 
commercializes shall be encour-
aged to make such payment.
  The Governing Body shall, at 
its fi rst meeting, determine the 
level, form and manner of the 
payment, in line with commercial 
practice. The Governing Body 
may decide to establish different 
levels of payment for various 
categories of recipients who com-
mercialize such products; it may 
also decide on the need to exempt 
from such payments small farm-
ers in developing countries and 
in countries with economies in 
transition. The Governing Body 
may, from time to time, review 
the levels of payment with a view 
to achieving fair and equitable 
sharing of benefi ts, and it may 
also assess, within a period of 
five years from the entry into 
force of this Treaty, whether the 
mandatory payment requirement 
in the MTA shall apply also in 
cases where such commercialized 
products are available without 
restriction to others for further 
research and breeding.
13.3 The Contracting Parties agree that ben-
efi ts arising from the use of plant genetic 
resources for food and agriculture that 
are shared under the Multilateral Sys-
tem should fl ow primarily, directly and 
indirectly, to farmers in all countries, 
especially in developing countries, and 
countries with economies in transition, 
who conserve and sustainably utilize 
plant genetic resources for food and 
agriculture.
13.4 The Governing Body shall, at its fi rst 
meeting, consider relevant policy and 
criteria for specific assistance under 
the agreed funding strategy established 
under Article 18 for the conservation 
of plant genetic resources for food and 
agriculture in developing countries, and 
countries with economies in transition 
whose contribution to the diversity of 
plant genetic resources for food and 
agriculture in the Multilateral System 
is signifi cant and/or which have special 
needs.
13.5 The Contracting Parties recognize that 
the ability to fully implement the Global 
Plan of Action, in particular of develop-
ing countries and countries with econo-
mies in transition, will depend largely 
upon the effective implementation of 
this Article and of the funding strategy 
as provided in Article 18.
13.6 The Contracting Parties shall consider 
modalities of a strategy of voluntary 
benefi tsharing contributions whereby 
Food Processing Industries that benefi t 
from plant genetic resources for food 
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and agriculture shall contribute to the 
Multilateral System.
Article 15 - Ex Situ Collections of 
Plant Genetic Resources for Food and 
Agriculture held by the International 
Agricultural Research Centres of the 
Consultative Group on International 
Agricultural Research and other 
International Institutions
15.1 The Contracting Parties recognize the 
importance to this Treaty of the ex situ 
collections of plant genetic resources 
for food and agriculture held in trust by 
the International Agricultural Research 
Centres (IARCs) of the Consultative 
Group on International Agricultural 
Research (CGIAR). The Contracting 
Parties call upon the IARCs to sign 
agreements with the Governing Body 
with regard to such ex situ collections, 
in accordance with the following terms 
and conditions:
(a) Plant genetic resources for food and 
agriculture listed in Annex I of this 
Treaty and held by the IARCs shall 
be made available in accordance 
with the provisions set out in Part 
IV of this Treaty.
(b) Plant genetic resources for food and 
agriculture other than those listed in 
Annex I of this Treaty and collected 
before its entry into force that are 
held by IARCs shall be made avail-
able in accordance with the provi-
sions of the MTA currently in use 
pursuant to agreements between the 
IARCs and the FAO. This MTA shall 
be amended by the Governing Body 
no later than its second regular ses-
sion, in consultation with the IARCs, 
in accordance with the relevant 
provisions of this Treaty, especially 
Articles 12 and 13, and under the 
following conditions:
(i) The IARCs shall periodically in-
form the Governing Body about 
the MTAs entered into, according 
to a schedule to be established by 
the Governing Body;
(ii) The Contracting Parties in whose 
territory the plant genetic re-
sources for food and agriculture 
were collected from in situ con-
ditions shall be provided with 
samples of such plant genetic re-
sources for food and agriculture 
on demand, without any MTA;
(iii) Benefi ts arising under the above 
MTA that accrue to the mecha-
nism mentioned in Article 19.3f 
shall be applied, in particular, to 
the conservation and sustainable 
use of the plant genetic resources 
for food and agriculture in ques-
tion, particularly in national and 
regional programmes in devel-
oping countries and countries 
with economies in transition, 
especially in centres of diversity 
and the least developedcoun-
tries; and
(iv) The IARCs shall take appro-
priate measures, in accordance 
with their capacity, to main-
tain effective compliance with 
the conditions of the MTAs, 
and shall promptly inform the 
 Governing Body of cases of non-
 compliance.
(c) IARCs recognize the authority of the 
Governing Body to provide policy 
guidance relating to ex situ collec-
tions held by them and subject to the 
provisions of this Treaty.
(d) The scientifi c and technical facili-
ties in which such ex situ collections 
are conserved shall remain under 
the authority of the IARCs, which 
under take to manage and administer 
these ex situ collections in accordance 
with internationally accepted stand-
ards, in particular the Genebank 
Standards as endorsed by the FAO 
ISSUES IN GENETIC RESOURCES NO. 12
C. FOWLER, J. ENGELS AND E. FRISON  (COMPILERS)
37
Commission on Genetic Resources 
for Food and Agriculture.
(e) Upon request by an IARC, the 
 Secretary shall endeavour to provide 
appropriate technical support.
(f) The Secretary shall have, at any time, 
right of access to the facilities, as 
well as right to inspect all activities 
performed therein directly related to 
the conservation and exchange of the 
material covered by this Article.
(g) If the orderly maintenance of these 
ex situ collections held by IARCs is 
impeded or threatened by whatever 
event, including force majeure, the Sec-
retary, with the approval of the host 
country, shall assist in its evacuation 
or transfer, to the extent possible.
15.2 The Contracting Parties agree to pro-
vide facilitated access to plant genetic 
resources for food and agriculture in 
Annex I under the Multilateral Sys-
tem to IARCs of the CGIAR that have 
signed agreements with the Governing 
Body in accordance with this Treaty. 
Such Centres shall be included in a 
list held by the Secretary to be made 
available to the Contracting Parties on 
request.
15.3 The material other than that listed in 
 Annex I, which is received and con-
served by IARCs after the coming into 
force of this Treaty, shall be available for 
access on terms consistent with those 
mutually agreed between the IARCs 
that receive the material and the country 
of origin of such resources or the coun-
try that has acquired those resources 
in accordance with the Convention on 
Biological Diversity or other applicable 
law.
15.4 The Contracting Parties are encouraged 
to provide IARCs that have signed 
agreements with the Governing Body 
with access, on mutually agreed terms, 
to plant genetic resources for food and 
agriculture not listed in Annex I that 
are important to the programmes and 
activities of the IARCs.
15.5 The Governing Body will also seek to 
establish agreements for the purposes 
stated in this Article with other relevant 
international institutions.
Article 21 – Compliance
The Governing Body shall, at its fi rst meet-
ing, consider and approve cooperative 
and  effective procedures and operational 
mechanisms to promote compliance with 
the provisions of this Treaty and to address 
issues of non- compliance. These procedures 
and mechanisms shall include monitoring, 
and offering advice or assistance, including 
legal advice or legal assistance, when needed, 
in particular to developing countries and 
 countries with economies in transition.
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International Treaty on Plant Genetic Resources For Food And Agriculture
ANNEX I: LIST OF CROPS COVERED UNDER THE MULTILATERAL SYSTEM
FOOD CROPS
Crop Genus Observations




Brassica complex Brassica et al. Genera included are: Brassica, 
Armoracia, Barbarea, Camelina, 
Crambe, Diplotaxis, Eruca, Isatis, 
Lepidium, Raphanobrassica, 
Raphanus, Rorippa, and Sinapis. 
This comprises oilseed and 
vegetable crops such as cabbage, 
rapeseed, mustard, cress, rocket, 
radish, and turnip. The species 




Citrus Citrus Genera Poncirus and Fortunella 
are included as root stock.
Coconut Cocos
Major aroids Colocasia, Xanthosoma Major aroids include taro, 











Cassava Manihot Manihot esculenta only.
Banana / Plantain Musa Except Musa textilis.
Rice Oryza
Pearl Millet Pennisetum
Beans Phaseolus Except Phaseolus polyanthus.
Pea Pisum
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Potato Solanum Section tuberosa included, except 
Solanum phureja.
Eggplant Solanum Section melongena included.
Sorghum Sorghum
Triticale Triticosecale
Wheat Triticum et al. Including Agropyron, Elymus, and 
Secale.
Faba Bean / Vetch Vicia
Cowpea et al. Vigna
Maize Zea Excluding Zea perennis, Zea 








Lathyrus cicera, ciliolatus, hirsutus, ochrus, odoratus, sativus
Lespedeza cuneata, striata, stipulacea
Lotus corniculatus, subbifl orus, uliginosus
Lupinus albus, angustifolius, luteus
Medicago arborea, falcata, sativa, scutellata, rigidula, truncatula
Melilotus albus, offi cinalis
Onobrychis viciifolia
Ornithopus sativus
Prosopis affi nis, alba, chilensis, nigra, pallida
Pueraria phaseoloides
Trifolium alexandrinum, alpestre, ambiguum, angustifolium, arvense, agrocicerum, 
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Festuca arundinacea, gigantea, heterophylla, ovina, pratensis, rubra
Lolium hybridum, multifl orum, perenne, rigidum, temulentum
Phalaris aquatica, arundinacea
Phleum pratense
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Annexe 3: Material Transfer Agreement (MTA) (1998)
The material contained herein is being 
furnished by [Centre] under the following 
conditions:
Designated Germplasm
[Centre] is making the material described in 
the attached list available as part of its policy 
of maximizing the utilization of genetic ma-
terial for research. The material was either 
developed by [Centre]; or was acquired prior 
to the entry into force of the Convention on 
Biological Diversity; or if it was acquired after 
the entering into force of the Convention on 
Biological Diversity, it was obtained with the 
understanding that it could be made freely 
available for any agricultural research or 
breeding purposes.
The material is held in trust under the terms 
of an agreement between [Centre] and FAO, 
and the recipient has no rights to obtain 
Intellectual Property Rights (IPR) on the 
germplasm or related information.
The recipient may reproduce the seed and 
use the material for agricultural research 
and breeding purposes and may distribute 
it to other parties provided the recipient is 
also willing to accept the conditions of this 
agreement.1 
The recipient, therefore, hereby agrees not to 
claim ownership over the germplasm to be 
received, nor to seek IPR over that germplasm 
or related information. He/She further agrees 
to ensure that any subsequent person or in-
stitution to whom he/she may make samples 
of the germplasm available, is bound by the 
same provision and undertakes to pass on 
the same obligations to future recipients of 
the germplasm.
[Centre] makes no warranties as to the safety 
or title of the material, nor as to the accuracy 
or correctness of any passport or other data 
provided with the material. Neither does it 
make any warranties as to the quality, viabil-
ity, or purity (genetic or mechanical) of the 
material being furnished. The phytosanitary 
condition of the material is warranted only 
as described in the attached phytosanitary 
certificate. The recipient assumes full re-
sponsibility for complying with the recipient 
nation’s quarantine/biosafety regulations 
and rules as to import or release of genetic 
material.
Upon request, [Centre] will furnish informa-
tion that may be available in addition to what-
ever is furnished with the seed. Recipients are 
requested to furnish [Centre] performance 
data collected during evaluations.
The material is supplied expressly condi-
tional on acceptance of the terms of this 
agreement. The recipient’s acceptance of the 
material constitutes acceptance of the terms 
of this Agreement.
1 This does not prevent the recipient from releasing or reproducing the seed for purposes of making 
it directly available to farmers or consumers for cultivation, provided that the other conditions set 
out in the MTA are complied with.
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Annexe 4: Material Transfer Agreement for Plant Genetic Resources Held in 
Trust by the [Centre]1,2 (2003)
The plant genetic resources (hereinafter re-
ferred to as the “material”) contained herein 
are being furnished by the [Centre] under the 
following conditions:
The [Centre] is making the material described 
in the attached list available as part of its pol-
icy of maximizing the utilization of material 
for research, breeding and training. The mate-
rial was either developed by the [Centre]; or 
was acquired prior to the entry into force of 
the Convention on Biological Diversity; or if 
it was acquired after the entering into force 
of the Convention on Biological Diversity, it 
was obtained with the understanding that it 
could be made available for any agricultural 
research, breeding and training purposes 
under the terms and conditions set out in 
the agreement between the [Centre] and FAO 
dated 26 October 1994.
The material is held in trust under the terms of 
this agreement, and the recipient has no rights 
to obtain Intellectual Property Rights (IPRs) on 
the material or related information.
The recipient may utilize and conserve the 
material for research, breeding and training 
and may distribute it to other parties pro-
vided such other parties accept the terms and 
conditions of this agreement.3
The recipient, therefore, hereby agrees not 
to claim ownership over the material, nor to 
seek IPRs over that material, or its genetic 
parts or components, in the form received. 
The recipient also agrees not to seek IPRs over 
related information received.
The recipient further agrees to ensure that any 
subsequent person or institution to whom 
he/she may make samples of the material 
available, is bound by the same provisions 
and undertakes to pass on the same obliga-
tions to future recipients of the material.
The [Centre] makes no warranties as to the 
safety or title of the material, nor as to the ac-
curacy or correctness of any passport or other 
data provided with the material. Neither does 
it make any warranties as to the quality, vi-
ability, or purity (genetic or mechanical) of the 
material being furnished. The phytosanitary 
condition of the material is warranted only 
as described in the attached phytosanitary 
certificate. The recipient assumes full re-
sponsibility for complying with the recipient 
nation’s quarantine and biosafety regulations 
and rules as to import or release of genetic 
material.
Upon request, the [Centre] will furnish 
information that may be available in ad-
dition to whatever is furnished with the 
material. Recipients are requested to fur-
nish the [Centre] with related data and 
information collected during evaluation 
and utilization.
1 This MTA covers materials which are being transferred before the entry into force of the 
International Treaty on Plant Genetic Resources for Food and Agriculture. The Treaty envisages 
that the [Centre] will enter into an agreement with the Governing Body of the Treaty, once the 
Treaty enters into force. The [Centre] has indicated its intention to conclude such an agreement 
with the Governing Body. This agreement, in line with the Treaty, will provide for new MTAs and 
benefi t-sharing arrangements for materials transferred after the entry into force of the agreement.
2 The attention of the recipient is drawn to the fact that the details of the MTA, including the identity 
of the recipient, will be made publicly available.
3 This does not prevent the recipients from releasing the material for purposes of making it directly 
available to farmers or consumers for cultivation, provided that the other conditions set out in this 
MTA are complied with.
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The recipient of material provided under 
this MTA is encouraged to share the benefi ts 
accruing from its use, including commercial 
use, through the mechanisms of exchange 
of information, access to and transfer of 
technology, capacity building and sharing 
of benefi ts arising from commercialization. 
The [Centre] is prepared to facilitate the 
sharing of such benefi ts by directing them to 
the conservation and sustainable use of the 
plant genetic resources in question, particu-
larly in national and regional programmes 
in developing countries and countries with 
economies in transition, especially in cen-
tres of diversity and the least developed 
countries.
The material is supplied expressly condi-
tional on acceptance of the terms of this 
Agreement. The recipient’s acceptance of the 
material constitutes acceptance of the terms 
of this Agreement.
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Annexe 5: [First] Joint Statement of FAO and the CGIAR Centres on the 
Agreement Placing CGIAR Germplasm Collections under the Auspices of 
FAO (1994)
The International Agricultural Research 
Centres of the Consultative Group on Inter-
national Agricultural Research (the Centres), 
which hold plant genetic resources in trust 
in their genebanks, listed at the end of this 
joint statement, have placed these collections 
under the auspices of FAO as part of the In-
ternational Network of Ex Situ Collections, 
under agreements signed with FAO (the 
Agreement).
The text of the Agreement is essentially 
that approved by the Commission on Plant 
Genetic Resources (CPGR) in April 1993 and 
the FAO Conference in November 1993 with 
the modifi cations introduced into the text to 
refl ect the concerns expressed by the CPGR 
on certain points. The modifi cations deal with 
(i) clarifi cation of the concept of trusteeship 
and benefi ciary, in particular as it relates to 
the concept of ownership; (ii) obligations with 
respect to the conservation of germplasm and 
its availability that would flow from the 
concept; (iii) the policy role of the CPGR; and 
(iv) the duration of the agreement and 
opportunities for its review by the CPGR.
The modifi ed draft agreement was further 
commented on by the Working Group of the 
CPGR at its ninth session (Rome, 11-12 May 
1994), which expressed its concern that the 
draft agreement, substantially in its present 
form should be concluded as soon as possible. 
In so doing the Working Group drew 
attention to the need to clarify the implication 
of the words “without restriction” at the end 
of Article 9, in the light of the Convention on 
Biological Diversity and the ongoing process 
of renegotiation of the International 
Undertaking on Plant Genetic Resources. It 
was suggested that the words either be 
deleted or be clarifi ed in a joint statement, by 
the parties to the agreement, to be presented 
to the CPGR. The text of the Agreement to be 
signed on 26 October 1994 is identical to that 
presented to the Working Group in May 1994, 
with the addition, at the beginning of Article 
9, of the expression “Subject to the provisions 
of Article 10 below”.
In considering the final text of the 
Agreement, the common understanding of 
the parties concerning certain of its provisions 
is hereby communicated to the Commission 
on Plant Genetic Resources as follows:
1. Article 3(b): This article does not prevent 
the Centres from using instruments such 
as material transfer agreements when 
they are designed to ensure the materials 
distributed remain in the public domain 
as is required under Article 10.
2. Article 3(b): The words “related informa-
tion” at the end of Article 3(b) refer to 
information which has been compiled 
with respect to individual accessions. 
Such information includes passport and 
characterization data and, when avail-
able in the databases of the respective 
genebanks, evaluation data and informa-
tion on indigenous knowledge.
3. Article 9: The words “without restriction” 
at the end of Article 9 should be inter-
preted consistently with the Convention 
on Biological Diversity and as not in any 
way affecting the rights of countries of 
origin under this Convention.
4. Article 9: The words “Subject to the provi-
sions of Article 10 below” were added at 
the beginning of the Article to clarify that 
the words “without restriction” in Article 
9 are not interpreted as a limitation on the 
ability of the Centres to obtain commit-
ments from persons and entities receiv-
ing samples of designated germplasm as 
stated in Article 10
5. Article 10: With respect to the transfer of 
samples of designated germplasm, the 
requirements of Article 10 will be satisfi ed 
by arrangements, such as material transfer 
agreements, that require the recipient not 
to seek intellectual property protection on 
the material and to pass on the same obli-
gation to subsequent recipients. Similarly, 
with respect to the transfer of duplicates 
of collections, or parts thereof, for safety 
purposes, the requirements of Article 10 
will be satisfi ed by an agreement under 
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which the recipient institution undertakes 
to observe the maintenance obligations 
set out in Article 5(a). However, in neither 
case will the source Centre be under an 
obligation to monitor the compliance of 
the recipient with these undertakings; 
the obligation of the source Centre will be 
limited to obtaining such undertakings on 
the part of the recipient.
6. The parties to the Agreement recognize 
that the conclusion of the Agreement 
represents but one stage of a continuing, 
dynamic process and agree to continue 
the dialogue in the context of the imple-
mentation of the Convention on Biological 
Diversity and the FAO Global System on 
Plant Genetic Resources. They will consult 
from time to time to review these matters 
and to consider such modifi cations as may 
be appropriate in the circumstances.
 Centro Internacional de Agricultura Tropi-
cal (CIAT)
 Centro Internacional de Mejoramiento de 
Maiz y Trigo (CIMMYT)
 Centro Internacional de la Papa (CIP)
 International Center for Agricultural 
 Research in the Dry Areas (ICARDA)
 International Center for Research in Agro-
forestry (ICRAF)
 International Crops Research Institute for 
the Semi-Arid Tropics (ICRISAT)
 International Institute for Tropical 
 Agriculture (IITA)
 International Livestock Centre for Africa 
(ILCA)
 International Plant Genetic Resources 
 Institute (IPGRI)/International Network 
for the Improvement of Banana and 
 Plantain (INIBAP)
 International Rice Research Institute 
(IRRI)
 West Africa Rice Development Associa-
tion (WARDA)
 Centre for International Forestry Research 
(CIFOR)
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Annexe 6: Second Joint Statement of FAO and the CGIAR Centres on the 
Agreement Placing CGIAR Germplasm Collections under the Auspices of FAO 
(1998)
A Joint Statement issued by FAO and the 
CGIAR in conjunction with the signing of 
the FAO-CGIAR Agreements placing CGIAR 
Germplasm Collections under the auspices of 
FAO observed that: 
"The parties to the Agreement recog-
nize that the conclusion of the Agree-
ments represents but one stage of a 
continuing, dynamic process and agree 
to continue the dialogue in the context 
of the implementation of the Conven-
tion on Biological Diversity and the 
FAO Global System on Plant Genetic 
Resources. They will consult from time 
to time to review these matters and to 
consider such modifi cation as may be 
appropriate in the circumstances."
FAO and the CGIAR have consulted fre-
quently since the Agreements were con-
cluded in 1994 in order to review the 
implementation of the Agreements. 
The Parties understand and agree that:
While Centres distribute germplasm 
designated under  the  FAO/CGIAR 
Agreements through Material Transfer 
Agreements which prohibit the recipient, or 
any subsequent recipient, from taking out 
intellectual property rights, the CGIAR 
cannot guarantee that recipients will abide 
by the terms of the MTA.  Violations may take 
place.  However, in such cases the Parties 
commit themselves to taking appropriate 
remedial action, in accordance with the 
following agreed procedures:
When Centres become aware of a possible 
violation of their MTAs by a recipient of 
germplasm, the Centres will henceforth 
voluntarily undertake the following actions 
in response to the perceived violation.
1. The Centres will request an explanation. 
Upon failure to receive a satisfactory and 
timely explanation for the situation from 
the germplasm recipient, the Centres 
will notify the recipient that a violation 
is thought to have occurred and request 
that the recipient cease and desist in its ef-
forts to obtain intellectual property rights 
over the material, or renounce such rights 
or ownership if they have already been 
granted or claimed.
2. The Centres will notify the proper regula-
tory body in the relevant country of the 
possibility that the MTA has been violated, 
and bring to their attention the fact that 
the grant of intellectual property rights 
may, therefore, have been inappropriate 
in the case of the material obtained from 
the CGIAR.
3. The Centres will notify IPGRI and the 
FAO Commission on Genetic Resources 
for Food and Agriculture, through its 
Secretariat, of the possible violation of the 
MTA under the Agreements with FAO.
The Centres reserve the right to take 
other action, including legal action, as they 
might deem feasible and appropriate to en-
force the MTAs and preserve the integrity of 
the Agreements with FAO.  In this regard, it 
would be the intent of the Centres to work in 
cooperation with FAO, under whose auspices 
the materials are held in trust by the CGIAR 
for the benefit  of  the international 
community.
The Centres recognize that many 
accessions designated under the Agreements 
with FAO, were distributed to plant breeders 
and researchers prior to designation in 
keeping with the CGIAR policy for providing 
“unrestricted availability” to germplasm - as 
noted in the Preamble of Agreements.  In 
dealing with this situation, Centres will 
request and urge that no intellectual property 
rights be sought for designated germplasm 
that was distributed prior to its designation 
under the FAO-CGIAR Agreement.
Periodic reports will be presented to the 
Commission on Genetic Resources for Food 
and Agriculture on the actions taken in 
support of the objectives of the Agreements 
between the CGIAR Centres and FAO.
In considering the text of the Agreement, 
the common understanding of the parties 
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concerning certain of its provisions is, as 
follows:
Under the terms of the Agreements 
(Article 9), the Centres undertake “to make 
samples of the designated germplasm 
available directly to users or through FAO for 
the purpose of scientific research, plant 
breeding or genetic resource conservation, 
without restriction.” It is implicit in this 
undertaking that users will make only 
reasonable requests for these specific 
purposes, and that the liability of the Centres 
would not extend to the fulfillment of 
unreasonable requests. 
Sound management practices as well as 
practical or even biological constraints (such 
as seed availability or the health status of a 
sample) may at times make it diffi cult or 
inappropriate for centres to provide 
germplasm designated under the Agreements 
for the purposes spelled out in Article 9. It is 
understood that centres must use some 
discretion in determining the size and 
number of samples to be provided at any 
given time to a particular recipient. Centres 
are not obligated to distribute seed or other 
designated materials when such distributions 
would reduce stocks below accepted levels 
for conservation purposes, or when the 
request is for such a number of samples or 
quantity of a particular accession as to pose 
an undue burden on the fi nancial or technical 
resources of the centre or on its ability to meet 
requests from others.  In such cases, the centre 
may ask that the recipient cover the actual 
costs of multiplying the relevant accessions. 
In cases of limited supplies, immediate 
availability of materials cannot be guaranteed. 
Such availability will follow a process of 
multiplication. Centres are not obligated to 
supply quantities of a sample which exceed 
basic requirements for the purposes stated in 
Article 9. Recipients are advised that they 
may need to undertake their own seed 
multiplication when existing sample sizes are 
small (such as in the case with many 
accessions of wild relatives) or when demand 
for a particular sample exceeds supply.  In 
fi ling requests for material for conservation 
purposes alone, users are invited to note the 
Global Plan of Action’s objectives of 
“safeguarding as much existing unique and 
valuable diversity as possible in ex situ 
collections,” while reducing “unnecessary 
and unplanned redundancy in current 
programmes.”
In cases when a centre cannot fully or 
immediately meet a request, the centre will 
enter into a discussion with the requesting 
entity to develop and agree upon a plan and 
schedule for the supply of materials. This 
process might establish an agreed list of 
accessions to which priority would be given.
Some designated accessions cannot be 
multiplied without considerable cost. For 
example, certain accessions of woody species 
may take upwards of 10 hectares of land and 
30 years to multiply. Similarly, supplying 
materials of vegetatively propagated species 
can involve very time-consuming and expen-
sive procedures. While centres endeavour to 
supply materials free of cost, in such circum-
stances it would be unreasonable to expect 
that centres could guarantee unlimited quan-
tities or immediate availability of all desig-
nated germplasm. Users are encouraged to 
exercise good judgement and appropriate 
constraint in requests for such materials. At 
their discretion, centres may request that us-
ers cover all or part of the costs involved in 
multiplication.
Centres are neither obligated nor advised 
to distribute samples that do not meet health 
or quarantine standards, or whose transfer 
could pose the danger of a spread of pests or 
disease. Centres will inform those requesting 
materials of the danger which might be posed 
by invasiveness in those cases where they 
perceive such dangers to be signifi cant, and 
of the need for the prior informed consent of 
the recipient Government for the import of 
such materials. Materials will then be sup-
plied upon receipt of such prior informed 
consent.
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Article 2 provides that “The list of desig-
nated germplasm will be updated every two 
years as new accessions are added to the 
collection.” This does not preclude Centres 
from adding new germplasm to the list of 
designated germplasm without having to 
wait for the biennial updating of the lists. In 
such cases, the status of particular germ-
plasm as “designated germplasm” becomes 
effective immediately upon a centre’s deter-
mining that it is designating the germplasm 
under the Agreement and managing the 
germplasm under the terms of the Agree-
ment. The additional designations will be 
consolidated into updated lists, which will 
be notifi ed to FAO every two years or more 
frequently as may be appropriate.
As management and information systems 
improve and as genomic information about 
accessions becomes available, centres will 
update the list of materials covered under the 
Agreements. In addition to adding new 
materials, centres may fi nd, for example, that 
particular accessions have been designated 
more than once; that an accession’s 
registration number conveyed to FAO on the 
list of designated germplasm referred to in 
Article 2, may be incorrect or no longer 
correspond to an actual accession in the 
centre’s genebank; or that an accession may, 
through natural or accidental causes, have 
lost viability. Logically, such “accessions” will 
no longer be considered as designated under 
the terms of the Agreement. The Centre or 
Centres concerned will notify FAO of any 
proposals for the deletion of accessions from 
the list of designated germplasm for such 
reasons and will provide FAO with a 
statement of the reasons therefore.
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